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Gene regulation in mammals is a cornerstone issue in developmental biology.   One 
example of gene regulatory elements are enhancers, which have been shown in 
transfection assays to be cis-regulatory sequences that activate transcription regardless of 
location and orientation to their gene promoters.  However, no studies have examined in 
vivo whether the distance of a mammalian enhancer is critical for its function, and 
whether enhancers affect other genes beyond proximal regulatory domains.  One 
significant mammalian enhancer is located within the immunoglobulin heavy chain (IgH) 
gene locus that spans a distance of 3 Mb on mouse chromosome 12.  The IgH locus 
contains variable (VH), diversity (DH), and joining (JH) gene segments, and constant 
region (CH) exons.  These IgH gene segments recombine early in bone marrow B-
lymphocyte differentiation to yield functional antigen receptor genes.  Coupled to this, it 
has been demonstrated that the Eµ intronic enhancer, located between the JH-Cμ intron, 
has a significant role in gene regulation, including V(D)J recombination.  The first 
project is to test whether the location of the Eµ enhancer is required for its function with 
respect to chromatin, transcription, and recombination.  The second project is to 
determine whether the Eµ enhancer affects other genes in cis within the IgH locus, or 
elsewhere in the murine genome.  For the first project, BAC transgenic mice were 
developed that have the Eµ enhancer in different locations and experiments assayed for 
changes in chromatin, transcription, and recombination as a result of the relocated Eµ 
enhancer.  Our results demonstrate that regions of heterochromatin are changed to 
euchromatin based on the location of the Eμ enhancer, and that when the location of the 
Eμ enhancer is changed, unique transcripts and gene rearrangements are induced.  For the 
ii 
second project, genome-wide DNase Hypersensitivity sequencing was performed on 
samples with the Eμ enhancer present and absent.  Several novel peaks associated with 
DNase-I sites within the IgH locus were identified, and some peaks were lost when the 
Eμ enhancer was absent.  Therefore, the Eμ enhancer has other unique gene regulatory 
features in its proximal domain, and each of the unique DHS peaks may serve a gene 
regulatory purpose for the IgH locus that needs further exploration.   
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Chapter 1:  The Critical Importance of the Eμ enhancer 
Introduction 
One major beauty in all of life is the ability of jawed vertebrates and their immune 
systems to recognize and efficiently remove foreign antigens as they are presented on a 
vast repertoire of substances.  Lymphocytes are integral to the adaptive immune system 
and are able to respond to individual antigens through the presence of antigen receptors 
present on their cell surface.  Such specialized lymphocytes arise from a common 
lymphoid progenitor (CLP) in the bone marrow that gives rise to B, T, and Natural Killer 
(NK) cells.  While NK cells lack antigen specificity, B and T cells both have monoclonal 
high affinity antigen receptors.  Two key differences separate B and T cells: (1) B-cells 
differentiate within the bone marrow tissue and T-cells differentiate in the thymus, and 
(2) upon encounter with antigen, B-cells have the ability to differentiate into antibody 
producing plasma cells, follicular B cells, or memory B cells, whereas T-cells 
differentiate into several other sub-types, each with a variety of functions.  Nonetheless, 
these two lymphocyte populations share one major characteristic. 
Though different in tissue origination and effector function, immature B and T 
cells each have antigen-specific receptors that are formed by the process of V(D)J 
recombination.  As puzzle pieces combine in a position-specific manner to produce a 
picture, so do the separate variable (V), diversity (D), and joining (J) gene segments 
rearrange and combine to produce a coding sequence that is able to generate diverse 
antigen receptors.  In total, there are seven antigen-receptor loci in B and T cells.  This 
includes the α, β, γ, and δ loci expressed in T-cells to produce the T-cell receptor, and the 
IgH and light (Igκ and Igλ) chain loci expressed in B-cells to produce a functional B-cell 
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receptor.  Hundreds of gene segments are within the V(D)J loci, and it is the assembly 
and combination of these gene segments during B-cell development that generates the 
large range of sequences that encode unique antigen recognition motifs.  While a 
comprehensive treatment of antigen loci rearrangement and their cis-regulatory elements 
includes the study of all seven antigen-receptor loci in B and T cells, the specific focus in 
this thesis is that of the cis-regulatory features that drive somatic recombination in pro-B 
cells on the mouse IgH chain locus, a 3 Mb region located on the long arm of 
chromosome 12 and approximately 5 Mb to the telomere. 
In order for V(D)J recombination to take place, the site-specific recombination 
activating (RAG) nuclease, which corresponds to the lymphoid moiety of V(D)J 
recombinase, is needed to catalyze the precise cutting and pasting of individual V, D, and 
J gene segments, along with the ubiquitously expressed DNA repair factors from the non-
homologous end joining pathway (Johnson et al., 2010).  V(D)J recombination is further 
restricted by epigenetic mechanisms to specific lymphocyte developmental stages.  Such 
epigenetic mechanisms maintain antigen receptor genes in a closed conformation, so that 
the needed RAG-mediated double strand breaks that result in the formation of an antigen 
receptor take place at only the appropriate loci.  For this reason, in the presence of RAG 
and despite large distances between gene segments, the IgH chain recombines to produce 
a functional antigen receptor in B-cells. 
Even within a lineage, the different V, D, and J loci are rearranged in a specific 
manner.  At the pro-B cell stage of B-cell development in the bone marrow D to JH 
recombination precedes VH to DJH recombination on the IgH locus.  Due to the highly 
orchestrated regulation of RAG recombinase that results in the recombination steps 
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necessary for an antigen receptor, the different domains of the IgH locus must be 
accessible to the recombinase in a cell and stage-specific manner.  Led by Fred Alt’s 
laboratory, the “accessibility hypothesis” predicted the presence of accessibility control 
elements (ACEs) at the individual antigen receptor loci that promote the ordered genetic 
rearrangements (Yancopoulos and Alt, 1985).  Using a combination of transgenic models 
and in vitro systems, both transcriptional enhancers and promoters were found to regulate 
the cell type-specific chromatin structure to determine the targeting of RAG recombinase.  
Later, the RAG nuclease-mediated cleavage of RSSs flanking the immunoglobulin gene 
segments was found to be developmentally regulated (Ji et al., 2010). 
Though the mouse IgH locus consists of three main gene segments that must be 
accessible to RAG recombinase in a stage and site specific manner, the IgH locus also 
contains several cis-regulatory elements that govern epigenetic changes, including gene 
transcription, chromatin, and V(D)J regulation.  This includes the intronic enhancer, Eμ, 
the 3’ IgH regulatory region (IgH 3’RR), and transcriptional promoters throughout the 
VH, DH, and CH gene segments.  These cis-regulatory elements have a significant role in 
gene expression.  They also serve as accessibility control elements (ACEs) to direct the 
common V(D)J recombinase for productive recombination events, and at the same, these 
cis-regulatory elements serve as a feedback mechanism to prevent further rearrangements 
from occurring. 
Arguably the most critical cis-regulatory element within the IgH locus is the Eμ 
enhancer, located in the intron between JH4 and the Cµ exons.  It was the first 
transcriptional enhancer identified in mammalian cells and consists of a 220 base pair 
(bp) enhancer core (cEμ) and two flanking matrix attachment regions (MARs) (Gillies et 
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al., 1983; Jenuwein et al., 1997).  Targeted deletion of these MARs showed they are not 
necessary for V(D)J recombination within the IgH locus (Sakai et al., 1999).  However, 
deletion of cEμ in pro-B cells affected chromatin modifications, transcription and 
reduced both, DH to JH and VH gene rearrangements, establishing this intronic enhancer as 
a foundational puzzle piece in B-cell antigen receptor development (Chakraborty et al., 
2009).  From this study and others, there was a correlation between recombinase 
accessibility and transcription that depended in large part on the presence or absence of 
the Eμ enhancer, demonstrating that enhancers are a means of regulating antigen receptor 
gene rearrangements, thereby allowing lymphocytes to respond to a diverse pool of 
individual antigens on their cell surface.  In order to understand the critical importance of 
the cis-regulatory role of the Eμ enhancer in the IgH locus, this introductory overview 
will cover B-cell development and antibody structure, the organization of the IgH locus 
and functional rearrangement of V(D)J gene segments, and cis-regulatory features in the 
IgH locus.  A clear understanding of this background will then enable transition remarks 
that illustrate how this thesis project builds upon previous experiments in novel ways. 
B-Cell development and Antibody Structure 
I.  B-Cell Development: From Hematopoietic Stem Cells to Mature B-Cell 
Predicated on F. Macfarlane Burnet’s clonal selection theory (Burnet 1957), and 
supported with an array of experimental evidence (Cohn et al., 2007), the vertebrate 
immune system generates a large pool of B cells, each containing an antibody molecule 
with a unique specificity.  In order for the “humoral” immune system to produce specific 
immunoglobulins targeted against a diverse array of pathogens, a variety of cell-surface 
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bound immunoglobulin species must be expressed on naïve B cells prior to antigen 
exposure.  The multitude of immunoglobulins are produced in large part by the 
mechanisms that control V(D)J recombination, but also by the signals transduced from 
the pre-B cell receptor (BCR), which allows the developing progenitor B cell in the bone 
marrow to continue through the maturation steps as it exits and encounters antigen in the 
periphery.  In brief, the major theme in B-cell development in the bone marrow is that 
cis-acting elements are necessary for successful gene rearrangement and the production 
of a protein, known as the B-cell receptor, which serves as a signal for the cell to enter 
the next stage of development.  
Given the highlighted V(D)J rearrangement mechanism in the presence of RAG 
protein, the recombination events that take place between Ig gene segments are carefully 
regulated in a cell-specific manner.  Known as allelic exclusion, most B cells express a 
single light (L) chain isotype, either Igκ or Igλ (isotype exclusion), and use only one of 
the two alleles of heavy (H) and light (L) chain genes.  These parameters enable each B 
cell to express a single H2L2 combination on their cell surface.  Different quality control 
steps ensure only a single H2L2 combination appears within the BCR.  The immune 
system’s ability to generate unique antibodies is dependent on the fact that prior to 
antigen stimulation, each naïve B-cell displays on its membrane several thousand 
identical copies of a single unique species of antibody, which serve as the BCR for that 
particular lymphocyte. 
The journey of B cells from their earliest stage to their completed maturation form 
is characterized by both external and internal molecular events that are cell lineage 
specific.  B cells are derived from a population of multifaceted pluripotent hematopoietic 
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stem cells (HSC) that reside in bone marrow niches optimal for their maintenance.  These 
pluripotent HSCs have extensive self-renewal capacity and they are also able to 
regenerate all blood cell types throughout life by differentiating into progenitor cells with 
gradually restricted developmental potential.  In the B-cell development pathway, an 
HSC first differentiates into multipotent progenitor cells (MPPs), which can produce both 
lymphoid and myeloid cells, but are no longer self-renewing stem cells.  Multipotent 
progenitors express the tyrosine kinase cell-surface receptor FLT3, which binds to the 
membrane bound FLT3 ligand on stromal cells. Signaling through FLT3 is needed for 
differentiation to the next stage called the common lymphoid progenitor (CLP).  While it 
used to be thought that the CLP gave rise to both the B-cell and T-cell lineages in culture, 
it remains unclear whether the CLP is a precursor for T cells.  A preceding stage, known 
as the early lymphoid progenitor (ELP), has been identified that gives rise to T-cell 
precursors that migrate from the bone marrow to the thymus and also to the common 
lymphoid progenitor (Purizaca et al., 2012). 
In order for precursor B-cells to be oriented towards their developmental pathway, 
a subpopulation of CLP cells differentiates into B220+ cells with the receptor for 
interleukin-7 (IL-7) present on their cell surface (Welinder et al., 2011).  This receptor is 
induced by FLT3 signaling and PU.1 transcription, and is required for the survival and 
further differentiation from the CLP to the earliest B-lineage cell.  The IL-7 cytokine is 
secreted by stromal cells and is required for both growth and maintenance of developing 
B-cells in mice.  Two additional essential molecules are provided by the stromal cells.  
First, stem-cell factor (SCF), a membrane bound cytokine on stromal cells, interacts with 
the receptor tyrosine kinase Kit (CD117) and serves to stimulate the growth of 
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hematopoietic stem cells and the earliest precursor B-cells.  Second, the chemokine 
CXCL12 is another essential factor produced constitutively by the stromal cells and is 
required for the early stages of B-cell development (Ratajczak et al., 2013).  Therefore, 
there is strict requirement of stromal cells, for both the interleukins they secrete and the 
provided cell-cell contact during early B-cell development in the bone marrow. 
Definitive B-cell commitment is tailored by the induction of several transcription 
factors.  The current model is that IL-7 signaling promotes E2A expression, which then 
cooperates with PU.1 to induce the expression of early B-cell factor (EBF) (Medina and 
Singh, 2005).  Together, E2A and EBF cooperate to drive the expression of proteins that 
determine the initial B-cell specific developmental step in the bone marrow, known as the 
pro-B cell stage (Figure 1A).  This pair of transcription factors in the early pro-B cell 
stage also cooperate to induce the expression of the key proteins necessary for heavy-
chain locus gene rearrangement, RAG1 and RAG2 of the V(D)J recombinase (Schatz and 
Swanson, 2011).  In the absence of E2A or EBF, initial heavy-chain gene rearrangements 
fail to occur.   
One other critical B-cell fate transcription factor is Pax5, also known as B-cell 
specific activator protein (BSAP), which is induced by E2A and EBF and suppresses 
alternate cell fates in early developing B lineage cells and activates B-cell specific genes 
such as CD19, Igα, and BLINK (Nutt et al., 1999).  Experimental evidence demonstrates 
that germline deletion of Pax-5 in pro-B cells has no effect on DH to JH recombination, 
but blocks development further down the B-cell pathway, which indicates that Pax-5 is 
required for commitment to the B-cell lineage (Zhang et al., 2006).  Two observations, 
one general and one Ig-specific, must be delivered here to understand the overall 
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development of B-cells in the bone marrow.  First, even at this point of the pro-B cell 
stage and up to the immature B-cell stage, the progenitor B-cells remain in contact with 
stromal cells, particularly the reticular stromal cells in the trabecular spaces of the bone 
marrow.  Then, with each stage maturation step, the developing B-cell migrates towards 
the central sinus of the marrow cavity until the immature B-cell journeys out of the bone 
marrow and into the peripheral lymphoid organs to become a mature B-cell.  Second and 
more importantly, while the aforementioned transcription factors, cytokines and receptor-
ligand interactions between common lymphoid progenitors and stromal cells give rise to 
the earliest B-lineage cell, the pro-B cell, the main theme from the pro-B cell stage to the 
immature B-cell stage is the fixed sequence rearrangement of one gene locus at a time 
(Figure 1A).  For this reason, successful V(D)J rearrangement is necessary for the 
expression of a complete immunoglobulin chain as an integral component of the pre-B-
cell receptor, and this initial heavy chain rearrangement is followed by a second 
rearrangement on the light-chain gene, which allows the immature B-cell to express a 
complete IgM antigen receptor at the cell surface where it is first tested for tolerance to 
self-antigens.  
It was known from cell line studies that antigen receptor loci rearrangements first 
take place on the heavy chain, followed by the light chain (Figure 1A).  In other words, 
DH to JH recombination takes place prior to VH to DJH, and that this ordered 
rearrangement is followed by VJL recombination, resulting in a precise arrangement of 
steps for the antigen receptor loci (Alt et al., 1984).  To map out the stages of B-cell 
development, it was an initial priority to define unique combinations of surface markers 
that could distinguish cells based on recombination status (Rajewsky 1996).  This 
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resulted in the identification of the cluster of differentiation (CD) antigens, and their 
different combinations allowed for the separation of B-cell development into consecutive 
stages.  Based off this mapping, as shown in Figure 1A, the order of B-cell development 
stages are as follows: pro-B cell, pre-BI cell, large pre-BII cell, small pre-BII cell, 
immature B cell, and mature resting B cell. 
In light of this, the Ig loci of hematopoietic stem cells have the germline 
configuration, which is in contrast to the B220+ CD19- CD117+ early pro-B cells, where 
in the presence of RAG1 and RAG2, the IgH locus undergoes DH to JH joining on both 
alleles of the heavy chain locus.  The diversity of the B-cell antigen-receptor repertoire is 
increased at the pro-B cell stage due to the presence of the enzyme terminal 
deoxynucleotidyl transferase (TdT).  This enzyme adds non-templated nucleotides, 
known as N-nucleotides at the joints between rearranged gene segments.  Also, later in 
the pro-B cell stage, a surrogate light chain (SLC) that contains λ5 and VpreB is 
expressed (Figure 1B).  Expression of the SL chain is induced by E2A and EBF, and the 
SL chain is encoded with non-rearranged genes that are distinct from the antigen-receptor 
loci.  The µ heavy chain assembles with the SL chain to form a “pre-BCR complex” at 
the cell surface (Figure 1B) (Karasuyama et al., 1990).  A successful “in frame” VH to 
DJH rearrangement leads to the production of intact µ heavy chains, which then stops any 
additional VH to DJH rearrangement on the other allele, and the cell is now a pre-BI cell 
(B220+ CD19+ CD117+).  A second rearrangement proceeds on one allele between a VH 
gene segment and the rearranged DJH sequence.  If both V(D)J recombination products 
are out of frame on the second allele, the pro-B cell is then eliminated by apoptosis and 
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no µ heavy chains are produced. It is estimated that 45% of pro-B cells are lost at this 
stage (Fang et al., 1996).    
On these pre-BI cells, the pre-BCR associates with Igα and Igβ on the cell 
surface, which are the signaling molecules for this receptor (Figure 1B) (Clark et al., 
2005; Martensson et al., 2007).  The expression of the pre-BCR complex has been shown 
to have importance on two levels.  First, it blocks additional IgH chain recombination by 
lowering both RAG expression (Grawunder et al., 1995) and VH transcription to reduce 
target accessibility (Schlissel et al., 1994).  This allows for a single rearranged V(D)J 
antigen receptor to be expressed in the pre-BCR.  If successful rearrangements happened 
at each Ig heavy chain allele, this would result in a B-cell producing two receptors of 
different antigen specificities.  Allelic exclusion prevents this so that only one of two 
alleles of a gene is expressed in a diploid cell (Melchers et al., 1999).  The pre-BCR 
continues to be expressed until the next maturation step, known as the large cycling pre-
BII cell stage (B220+ CD19+ CD25+).  Several rounds of cell division take place in this 
stage, and it is estimated that the population of cells with in-frame gene segments 
expands by 30 to 60 fold prior to the next stage (Hesslein et al., 2001).  RAG gene 
expression declines in large pre-BII cells, and after several divisions the cells become 
smaller and stop dividing.  As these cells exit the cell cycle and become small pre-BII 
cells, the SL chain is no longer detected, and second importance of the pre-BCR is 
observed, in that it initiates immunoglobulin light chain recombination.  RAG gene 
expression is turned up once more, and now the immunoglobulin light chain genes 
undergo recombination.  Complete synthesis of either the κ or λ light chain leads to the 
assembly of the B-cell receptor (BCR).  Similar to the heavy chain locus, the light chain 
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locus is also governed by the same allelic exclusion mechanism so that the lymphocyte 
expresses only one type of antigen receptor (Loffert et al., 1996).  Most B cells also show 
isotype exclusion, in that they express either the κ or λ light chain, but not both (Ma et al., 
1992).  Of particular note with immunoglobulin light chains is that they lack D-gene 
segments, and therefore rearrangement only takes place by V to J joining.   
The BCR associates with Igαβ and is expressed on the cell membrane as an 
anchored IgM antibody.  This cell is now an immature B cell (CD93+) and RAG 
expression is again decreased.  Immature B cells in the bone marrow now contact 
autoantigens via the BCR and are assessed for autoreactivity.  Such autoreactive BCRs 
may be replaced by non-autoreactive BCRs in a mechanism known as receptor editing, 
wherein a new light chain is generated through the expression of RAG.  After receptor 
editing, the IgM+ immature B cells also express IgD on their cell surface and migrate to 
the periphery and wait for antigen exposure (Figure 1A).  In peripheral lymphoid organs 
(spleen, lymph nodes), immature B cells further develop into resting naïve mature B cells 
(CD93-) that co-express both IgM and IgD.  The IgH locus in resting B cells exists 
somewhat in a closed chromatin state enriched in repressive histone modifications 
(Chowdhury et al., 2008; Jeevan-Raj et al., 2011).  In contrast, active histone marks are 
observed throughout the V(D)J region, including Eµ and the IgH 3’RR  and the open 
chromatin footprint remains from the early gene recombination events in pro-B cells 
(Daniel  et al., 2010; Wang et al., 2009).  Transcription still takes place in resting B cells 
throughout the IgH locus, starting at the VH promoter and going through the intronic 
switch (Sµ) region and Cµ/Cδ exons.  This encodes the BCR that consists of the Igµ and 
Igδ heavy chain genes.   
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Once resting naive mature B cells encounter antigen in a secondary lymphoid 
organ, they proliferate and then differentiate into germinal center B cells, which give rise 
to long-lived plasma cells and memory B cells.  Upon this event of antigen stimulation, 
B-cells undergo class switch recombination (CSR) to produce antibodies with the same 
variable region, but different constant region, allowing for different effector functions.  
The central mechanism is one by which the intervening sequences between two switch 
(S) regions that are upstream of the constant (C) region are deleted in response to specific 
cytokine stimulation from helper T cells.  This allows the assembled VH gene to be next 
to a new C-region that has a different effector function, but has the same antigen 
specificity.  This process is initiated by activation-induced cytidine deaminase (AID). 
AID targets the S region and converts cytosine to uracil, and the repairs of the 
guanine:uracil lesion lead to double-strand breaks and class switch recombination 
(Muramatsu et al., 2000). 
Another process, somatic hypermutation, also takes place in the germinal center 
of activated B cells.  It modifies the gene encoding the variable region of 
immunoglobulin heavy and light chains, and generates B cells with higher affinity 
antibody.  Somatic hypermutation contributes to the affinity maturation in the antibody 
response by inserting point mutations in Ig V(D)J DNA, which results in high affinity 
antibodies that are selected for antigen.  It has also been suggested as a mechanism to 
assist the host in finding evolving pathogens (Long and Lipsky, 2006).  Only a small 
fraction of the B cells express a BCR capable of binding to any particular antigen.  When 
these B cells bind their antigen, they become activated to proliferate and mature into 
antibody secreting plasma cells, which manufacture large amounts of antibody specific 
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for the activating antigen.  In order for any antibody to effectively bind antigen with high 
affinity and avidity, the immunoglobulin structure is critical to ensure a diverse response.  
II. Antibody Structure
The ability of the immune system to generate an antigen specific antibody
depends on the fact that, prior to antigen exposure, millions of naïve resting B cells 
circulate and each of these cells displays on its membrane several thousand identical 
copies of a single unique species of antibody that serve as B-cell receptors (BCRs) for 
that lymphocyte.  Though unique, each antibody shares many structural characteristics to 
allow for this intense diversity.   
Each antibody molecule is comprised of two identical heavy (H) and two identical 
(L) chains (Figure 2).  These chains are held together by disulfide bonds to form a 
symmetric Y-shaped tetramer.  Due to sequence similarity, each heavy and light chain 
can be sub-divided into two general regions, the variable region and the constant region. 
The variable region contains the antigen binding domain and is therefore highly 
polymorphic.  Yet, the specificity of each antibody is determined by the combination of 
the heavy and light chain variable regions.  This variable region can be further divided 
into four framework regions (FR) and three complementarity determining regions (CDR) 
(Kabat et al., 1991).  The CDRs are hypervariable and the FRs forms a beta-sheet 
structure that allows for a scaffold to hold CDRs in positions to contact antigens.  
Interestingly, there are fewer DH and JH gene segments than VH genes; however, the 
recombined DJH structure contributes significantly to the diversity of the variable part of 
the immunoglobulin structure because it encodes most of CDR3 (Atkinson et al., 1994).   
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While the specificity of each antibody is determined by the variable region, the 
constant region determines the mechanisms used to destroy antigens.  Mouse antibodies 
are divided into five different classes based on their structure and function: IgM, IgG, 
IgA, IgE, and IgD.  Intense diversity at the variable region and a variety of mechanisms 
guided by the constant region is needed at this stage in order to combat a diverse universe 
of pathogens.  The diversity of these BCRs prior to antigen exposure is dependent on the 
structure and function of the immunoglobulin locus.  In turn, the ability for a B-cell to 
express a functional BCR is directly dependent on the organization of the IgH regulatory 
domain and the cis-rearrangements of gene segments within this domain. 
IgH Locus Organization and Functional Rearrangement of V(D)J Gene 
Segments 
I.  Structure of the IgH Locus 
The loci encoding IgH is the largest multigene domain known in the mammalian 
genome and its structure is critical for one of the most complicated genetic functions in 
the nucleus, V(D)J recombination (Bolland et al., 2009).  The murine germline IgH locus 
may be subdivided into four major gene clusters, spread over nearly 3 Mb on the long 
arm of chromosome 12 (Zhou et al., 2002, Retter et al., 2007).  As shown in Figure 3, 
these regions include the variable (VH), diversity (DH), and joining (JH) gene segments, 
all upstream of several constant region exons.  The VH gene segments in mouse contains 
nearly 110 functional genes and 85 pseudogenes that are classified on sequence similarity 
into 16 VH gene families and are distributed over 2.5 Mb in the 5’ part of the locus 
(Johnston et al., 2006).  Three broad domains characterize the VH gene cluster as follows: 
(1) an interleukin-7 (IL-7) regulated domain that is about 5 Mb from the telomere and 
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consists of the largest VH family, the VHJ558 family, (2) an intermediate domain that 
consists of the VHQ52 family, and (3) the proximal 3’ domain that contains the VH7183 
gene family (Johnston et al., 2006).   Each functional VH gene has a lymphoid-specific 
promoter, followed by a leader sequence, leader intron, VH coding sequences, and 
recombination signal sequence (RSS).  These RSSs are the recognition sequences for the 
V(D)J recombinase proteins RAG1 and RAG2.   
Separated by a distance of 90 kilobases (kb) from the most proximal 3’ VH gene 
(7183.2.3) is the DH gene domain, which has a total length of ~52 kb and contains 10-15 
(Figure 3).  These gene segments can be grouped into four families based on sequence 
homology: DFL16, DSP2, DST4, and DQ52.  Each functional DH gene is flanked by one 
RSS on each end.  DFL16.1 is the most 5’ DH gene segment, which is then followed by 
the DSP gene segments that are repeated in 4.7 kb repeats.  DQ52 is the most proximal 
D-gene and is only separated by 700 bp from the next gene-segment of the IgH locus, the 
JH gene cluster.  There are 4 functional JH gene segments that are all located within a 1.3 
kb region.  Each JH gene segments is flanked by an RSS at the 5’ end.    Less than 300 bp 
from the last JH gene is the Eµ intronic enhancer, a 1 kb Xba I fragment between JH4 and 
the first Cµ exon. 
Downstream of the Eµ intronic enhancer are eight constant heavy (CH) regions 
that have between 4-6 exons, which include Cµ, Cδ, Cγ3, Cγ1, Cγ2b, Cγ2a, Cε, and Cα 
(Figure 3).  Each of these gene segments encodes three (α, δ and γ) or four (µ and ε) 
domains (CH1-3 or CH1-4) and are separated by large introns.  Each CH region encodes 
one of the different immunoglobulin isotypes (IgM, IgD, IgG, IgA, and IgE) (Dudley et 
al., 2005).  In the case of Igα, Igδ, and Igγ chains, a proline-rich hinge region is present 
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between the CH1 and CH2 domains, and this region allows for structural flexibility that 
assists in the binding of antibody to an antigen.  Except for Cδ, each constant region gene 
has its own intronic promoter.  Transcripts derived from these promoters are “sterile 
transcripts” and are not translated into proteins, but correlate with CSR. 
II. Functional Rearrangement of V(D)J Gene Segments
An understanding of the IgH locus structure is foundational to exploring how the
different gene clusters are imprecisely shuffled and rearranged to achieve the vast 
repertoire of custom-made antibodies for adaptive immunity.  Once this groundwork is 
laid, an overview of the important cis-regulatory features of the IgH locus will be 
outlined in order to present the main design and thesis of this project.  For, it is the 
precise position of these cis-regulatory elements that allow for the rearrangement of 
separate these VH, DH, and JH gene clusters. 
Diversity lies at the core of V(D)J recombination and is consequently the 
cornerstone mechanism that is responsible for the variety of immunoglobulin receptors.  
Such diversity comes from two sources.  First, combinatorial diversity is due to the 
numerous combinations of V, D, and J segments that may be arranged for different 
receptor specificity.  Second, junctional diversity stems from the imprecise joining of the 
V, D, and J gene segments. 
In order for recombination to take place between different V, D, and J gene 
segments, an RSS must be present at each unrearranged gene segment, and RAG 
recombinase must be recruited to the loci specified for rearrangement (Figure 4A).  These 
evolutionary conserved sequences represent direct targets for RAG nuclease.  Each RSS 
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consists of a highly conserved 7-bp sequence, known as the consensus heptamer (5’-
CACAGTG), and an AT-rich 9-bp nonamer consensus sequence (5’-ACAAAAACC).  
These sequences are separated by either 12 or 23-bp spacer sequence that is less 
conserved.  As a result, spacer length defines the two types of RSSs, termed 12-RSS and 
23-RSS.  Efficient recombination happens only between 12-RSS and 23-RSS, a 
restriction known as the 12/23 rule.  Also required for the cleavage reaction in vitro is 
Mg+2, while Mn+2 yields RAG-mediated nicking of a single RSS (van Gent et al., 1996).  
Following RAG binding, V(D)J recombination is initiated with the assistance of 
high mobility group proteins (HMG1/2), and synapsis takes place between segments that 
are flanked with dissymmetric RSSs (Figure 4A).  In vitro biochemical studies of RAG-
mediated RSS cleavage have provided evidence of a two-step ‘capture’ model of RSS 
synapsis involving RAG binding to a first RSS prior to the capture of a fit partner (Jones 
et al., 2002; Mundy et al., 2002).  It was even proposed that the detection of initial 
cleavage mostly occurred at 12-RSSs in vivo, which resulted in a so called ‘12RSS 
binding first’ model (Curry et al., 2005).  However, other studies have not shown such 
preferential RAG binding to either RSS cluster (Ji et al., 2010). 
After the gene segments are brought together, RAG nuclease cleaves the RSSs by 
nicking a single strand of DNA specifically at the border between the heptamer of RSS 
and the coding segment, which results in a double-strand break (Schlissel et al., 1993).  
The 3’-OH group at the nick site of the coding segment is then covalently linked to the 
opposing phosphodiester bond on the antiparallel strand by a transesterification reaction 
that results in a hairpin structure, which contains the nearby coding DNA, and a blunt 
signal end (Roth et al., 1993).  The broken ends are then processed and joined together 
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with the assistance of ubiquitously expressed DNA repair factors, including members of 
the non-homologous end joining pathway (DNA-dependent protein kinase, Ku, Artemis, 
DNA ligase IV, Cernunnos/XLF, Xrcc4 proteins, along with histone H2AX and the 
Mre11/Rad50/Nbs1 complex) (Lieber, 2010; Boboila et al., 2012).  The result of these 
interactions are a signal joint (SJ) and a coding joint (CJ) product that contains the exons 
and forms the antigen-binding region of the receptor.  The SJ structure is a back-to-back 
fusion of RSS heptamers and the CJ structure displays sequence variability at DNA 
junctions because of the nucleotide deletion and non-templated nucleotide addition.  The 
V(D)J rearranged gene segment maintains a correct reading frame in approximately one-
third of instances, and out-of-frame reading frames of CJ to account for the remaining 
two-thirds.  The one productive rearrangement then enables development of a potentially 
functional immunoglobulin at the pre-BCR stage of B-cell development in the bone 
marrow. 
Three levels of control have been proposed to localize the activity of V(D)J 
recombinase.  As previously mentioned, V(D)J recombination is specifically coordinated 
to the cell-lineage and developmental stage of the differentiating B-cell in the bone 
marrow.  There is a hierarchy for IgH rearrangements in pro-B cells, in that it starts with 
DH to JH rearrangement before the completion of the rearranged allele with the additional 
V gene segment (Subrahmanyam et al., 2012) (Figure 4B).  Moreover, IgH genes 
rearrange first, which is then followed by IgL genes.  In addition, another level of control 
that constrains the activity of V(D)J recombinase is the phenomenon of allelic exclusion.  
In this regard, Burnet’s clonal selection theory appears again, as the antigen receptor 
chain is only encoded by one of two alleles from the heavy and light chains, and this 
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ensures the specificity of the immune response depending on the antigen selection of 
discrete B cells restricted to a homogenous set of Ig receptors.  When a functionally 
relevant rearrangement that encodes for IgH and can associate with the pre-BCR, allelic 
exclusion results where through feedback inhibition, another rearrangement at the 
corresponding locus is prevented.  The “accessibility hypothesis” was originally 
formulated out of this context in an attempt to interpret cell-lineage and developmental 
stage specificities of V(D)J recombination, and in particular the accessibility hypothesis 
sought to explain the how the feedback inhibition down-modulates the accessibility of the 
remaining allele (Alt et al., 1984). 
The central prediction of the accessibility hypothesis is the existence of 
“accessibility control elements” (ACEs) at the individual antigen receptor genes that are 
required for the complete V(D)J recombination mechanism to proceed. Early transgenic 
mouse knockout studies identified both promoters and enhancers on Ig loci as ACEs that 
act to make the locus accessible to V(D)J recombinase (Ferrier et al., 1990; Bassing et al., 
2002).  However, mutations in germline enhancers led to inhibition of V(D)J 
recombination locus-wide, whereas mutations in germline promoters demonstrated 
localized inaccessibility of gene segments for recombination (Whitehurst et al., 1999).  
Yet, mutations in each case resulted in epigenetic chromatin changes (Whitehurst et al., 
2000), and targeted gene mutation of chromatin modifying factors that were known to 
bind to different ACEs of the IgH locus were shown to affect V(D)J recombination 
(Lazorchak et al., 2006; Johnson et al., 2008).  This finding was transitional for the 
accessibility hypothesis as it pointed to chromatin structure as one of the determining 
factors for V(D)J recombinase. 
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 Indeed, using an in vitro  system to investigate RAG mediated cleavage of RSSs 
flanking Ig gene segments in cell nuclei, Schlissel’s group demonstrated that chromatin 
structure is the machinery that targets V(D)J recombinase (Stanhope-Baker et al., 1996).  
They found a temporal ordering of gene segment rearrangement that is in line with cell 
type specificity to be dictated by the chromatin structure, which renders the accessibility 
of RSSs to RAG cleavage.  This was followed up with several chromatin 
immunoprecipitation experiments using antibodies raised against activating or 
suppressing histone modifications.  Many groups demonstrated the accessibility of the 
immunoglobulin loci to be dependent on epigenetic histone marks associated with gene 
activation, and the corollary to hold true, inaccessible immunoglobulin loci were marked 
with histone marks associated with gene silencing (Chowdhury and Sen, 2001; Morshead 
et al., 2003; Espinoza et al., 2005; Chakraborty et al., 2009).  In the case of the former, 
this includes histone acetylation for H3 and H4, and di/tri-methylation of lysine-4 on 
histone H3 (H3K4me2/me3), while in the case of the latter, this includes di/tri-
methylation of lysine-9 or lysine-27 on histone H3 (H3K9me2, H3K27Me3).  Further, a 
hierarchal establishment of locus-specific chromosome accessibility was established 
through the identification of discrete domains of RAG nuclease recruitment.  Such 
“hotspot” domains were associated with H3K4me2/me3, and the activating marks were 
significantly reduced by enhancer mutation (Spicuglia et al., 2002; Chakraborty et al., 
2009) (Figure 6).   
Several other genetic manipulation experiments have been executed to 
intentionally wield the accessibility of V(D)J recombination at individual gene segments. 
In one instance, the histone methyl transferase enzyme G9a, which mediates H3K9 
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methylation, was shown to override the ACEs function and diminish V(D)J 
recombination of chromosomal gene segments in the TCR locus (Osipovich et al., 2004). 
This included several histone alterations and showed how histone methyltransferases can 
revise the local chromatin environment and impair ACEs in a tissue and stage-specific 
manner during lymphocyte development.  Thus, the experimental weight pointed towards 
chromatin modifications as the major key that explains the accessibility hypothesis and 
the ACEs, as lineage specific RAG accessible and inaccessible immunoglobulin loci were 
discovered.  Nonetheless, these revisions were not isolated to the chromatin environment 
alone.  When a transcription terminator was introduced to block transcriptional 
elongation, this also suppressed chromatin remodeling and reduced recombination 
(Abarrategui et al., 2006).  As a result, the picture that emerged was that epigenetic 
chromatin modifications introduced changes at the level of DNA, which affected both 
transcription and the ability of chromatin remodeling complexes to remodel nucleosomes 
positioned at RSSs to either increase RSS accessibility to RAG cleavage or recruit RAG 
itself (Figure 6). 
 In order to elucidate the mechanism of RAG nuclease binding to RSSs of antigen 
receptor gene segments, it is first helpful to understand some background and the 
functional significance of the RAG protein.  RAG1 and RAG2 are two evolutionary 
conserved genes that are closely linked on chromosome 11 in humans and chromosome 2 
in mice.  RAG1 consists of a total of 1040 amino acids and has a core region that is 
essential for all in vivo and in vitro activities (amino acids 384-1008) (Sadofsky et al., 
1993; Silver et al., 1993).  RAG2 has 527 amino acids is comprised of a non-canonical 
plant homeodomain finger where, in several other proteins who function in epigenetic 
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regulation, binds to H3K4me2 or H3K4me3.  It has been demonstrated that this same 
domain directs the binding of RAG2 to H3K4me2 and H3K4me3 (Liu et al., 2007).  The 
functional significance of this binding by RAG has been demonstrated on three levels. 
First, mutations in this plant homeodomain removed H3K4me3 recognition, which then 
resulted in significantly lower amounts of V(D)J recombination (Liu et al., 2007).  
Second, the amount of H3K4me3 dictated the level of RAG DNA binding and 
recombination.  Third, RAG2 recognition of H3K4me3 stimulates the catalytic activity of 
the RAG nuclease, and consequently is likely to stabilize the newly excised 
recombination ends within the post-RAG cleavage complex that contains the non-
homologous end joining repair machinery (Grundy et al., 2010; Shimazaki et al., 2009; 
Wang et al., 2012). 
This sets the stage to understand the binding of the RAG nuclease to RSS-
containing sites of antigen receptor gene segments.  Led by David Schatz’s group, they 
executed several significant experiments using transgenic mice that expressed a RAG1 
protein and, while on the one hand binds DNA normally and interacts with RAG2, 
contained a mutated site in the active domain that resulted in no catalytic activity (Ji et 
al., 2010).  This mutation was at three residues (R391A, R393A, and R402A) and known 
to make critical contacts with the RSS nonamer.  It was shown that in the mutated RAG1 
setting, though RAG1 is expressed, lymphocyte development does not take place 
presumably due to no V(D)J recombination.  It was further established that RAG protein 
DNA binding takes place in a focal manner in minimal regions that are elevated in the 
active histone mark H3K4Me3 and have a RSS.  Formations of these local RAG-bound 
regions are referred to as “recombination centers,” and occur in a developmental stage 
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and lineage-specific manner.  The goal of these recombination centers is to coordinate 
V(D)J recombination by providing discrete sites within which antigen receptor gene 
segments are captured for recombination  (Jaeger et al., 2013).  Strikingly, it was found 
that on the TCR locus, it is the enhancers that control RAG1 binding globally in the DJ 
gene segment, and that promoters direct RAG1 locally in a manner that recapitulates the 
V(D)J gene rearrangement function of these accessible control elements as defined in 
earlier studies (Ji et al., 2010). 
To close this section, two hallmark features have emerged from recombination 
centers.  First, they are specialized site of high local RAG concentration associated with 
high active chromatin marks and second, where they exist, there is an array of multiple, 
closely spaced RSSs.  It remains to be determined whether the number and/or spacing of 
the RSSs are important for stable recruitment of the RAG proteins.  Even recent 
experimental evidence from recombined DJH alleles on the IgH locus in pro-B cells 
indicates that these DJH junctions bind RAG proteins and are epigenetically marked to 
permit the DJH-5’ RSSs to start the second step of IgH gene assembly (Subrahmanyam et 
al., 2012).  Therefore, while the accessibility hypothesis initially opened the case to 
explain allelic exclusion, in terms of the accessibility of V(D)J recombinase to ACEs 
through the opening or closing of chromatin structure in a cell-lineage and developmental 
stage specific manner, it was the “recombination center” model that has further explained 
the strict requirement for high local concentration of RAG tethered to an array of RSSs as 
necessary for each ordered V(D)J recombination step.  Together, each model, the 
accessibility hypothesis and recombination center, work in concert to explain the 
different levels of regulation for the functional V(D)J recombination mechanisms.  It is 
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precisely the accessibility of both an antigen receptor gene locus, and its ACEs, to the 
RAG recombinase that determines the specific selection of an antigen-receptor gene that 
will eventually recombine.  Consequently, these ACEs, namely enhancers, along with 
promoters and locus control regions, are then considered to be the “controllers” of RAG 
binding and the eventual recombination of genes.  Specifically, ACEs act in concert to 
open the chromatin structure and free the RSSs for RAG-binding to take place.  Such cis-
acting ACEs are then central to the core features of both the accessibility hypothesis and 
the posited recombination centers. 
In light of this, it is critical to give an overview of the cis-regulatory elements of 
the IgH locus on mouse chromosome 12.  From such an overview, an explanation will 
follow that communicates the significant role of the Eμ intronic enhancer and why it was 
selected for this thesis as an enhancer to study both cis-regulation as it relates to 
recombination, and cis-regulation to other, unknown areas of the IgH locus. 
Significant cis-Regulatory Features in the IgH locus 
I. Overview of cis-Regulatory Elements 
From the earliest stages of B-cell development in the bone marrow to the eventual 
maturation of an immature IgM B-cell, the differentiation into the tissue and stage-
specific cell types requires spatiotemporal patterns of gene expression and chromatin 
modifications that are regulated by cis-regulatory features in the non-coding DNA 
sequence.  These cis-regulatory elements control the nearby expression of genes and 
recruit multiple nuclear factors in order to ensure precise IgH locus regulation through 
directed physical interactions and potential functional consequences.  Prior to an 
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examination of the cis-acting genetic features on the IgH locus, an overview of cis-
regulatory elements initiates this section in order to better understand those elements on 
the IgH locus and the central priority of this thesis.   
In general, cis-regulatory elements include enhancers, promoters, chromatin 
insulators, silencers, and locus control regions.  Chromatin insulators serve to prevent the 
spread of inactive chromatin domains into the active gene cluster (Gaszner et al., 2006), 
and silencers are DNA sequences located typically upstream of the target gene and 
represses transcription.  Yet, the formation, organization and maintenance of many open 
chromatin domains is the role of the locus control region (LCR) (Li et al., 1999).  Similar 
to insulators, an LCR can overcome the positional effect when linked to a new gene that 
is inserted into a eukaryotic chromosome and enhance the expression of that gene to 
physiological levels in a tissue-specific and copy number dependent manner. Distinct 
from insulators, an LCR also stimulates the expression of genes contained within its 
functional domain. 
Unlike other cis-regulatory elements, the location and composition of LCRs 
relative to their cognate genes is not uniform.  The discovery of the position, integration-
site independent, and copy-number dependent LCR in the β-globin locus to drive the high 
expression of genes from transgenic mouse studies led to deletion studies of regions 
upstream of the gene (Grosveld et al., 1987), which resulted in a closed chromatin 
conformation spanning the whole locus and suppression of gene expression (Forrester et 
al. 1990).  This data suggested that the deleted DNA segment contained an indispensable 
cis-acting regulatory element required for beta –globin expression in vivo.  Other 
experiments centered on similar model systems demonstrated long-range gene activation 
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via LCR-mediated targeting and extensive spreading of core histone acetylation (Ho et 
al., 2002).  The LCR was therefore assumed to control chromatin structure and form 
active chromatin domains for gene activation.  While small deletions within individual 
LCR hypersensitive sites in transgenic human loci have been shown to result in gene and 
developmental-specific effects on LCR activity in of embryonic and fetal globin genes 
(Navas et al., 2003), no similar results have been obtained from endogenous loci and 
therefore the developmental specificity appears to be encoded elsewhere with the β-
globin LCR.  Evidence to date indicates that the endogenous mouse β-globin locus LCR 
is only present for enhancer-based activation of gene expression and the controllers of 
chromatin structure are in other cis-acting elements as LCR deleted alleles have regular 
levels of histone acetylation but significant reduction in β-globin transcription (Schubeler 
et al., 2001).  To summarize, the characterization of LCRs points to two significance 
features: (1) the regulation of gene expression by LCRs are developmental and cell 
lineage-specific, and (2) the reliance on both gene-proximal cis-acting elements and long-
range interactions of cis-regulatory elements may drive dynamic chromatin alterations to 
bring about the necessary patterns of gene expression for tissue specific cellular 
differentiation. 
While LCRs are cis-acting elements that organize gene clusters into an active 
chromatin domain for the purposes of enhancing transcription of genes in a tissue specific 
manner, it is the specific role of other cis-regulating elements, namely enhancers that 
coordinate with promoters to activate transcription.  One of the primary functions of an 
enhancer is to recruit DNA-binding proteins to the gene locus and provide diverse 
transcriptional instructions in order to regulate the level of gene expression necessary for 
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biological function.  Consequently, mutations in enhancers result in abnormal gene 
expression and may be the source for various disorders (Cho, 2012).  Enhancers are 
usually occupied by clusters of transcription factors that are free of nucleosomes and thus 
contain a distinguishing hypersensitive character; that is, one distinguishing feature of 
enhancers is their sensitivity to small amounts of DNase I as the chromatin is digested 
due to the open structural conformation. 
Enhancers are critically important cis-regulated gene expression controllers 
because it has long been experimentally suggested from transfection assays that 
“enhancers can activate transcription independent of their location, distance, or 
orientation with respect to the promoters of genes” (Ong et al., 2011; Banerji et al., 
1981).  Such a view is derived from positioning enhancers 5’ or 3’ to reporter genes and 
observing enhancer-mediated transcription.  These cis-regulatory enhancers are distinct 
from promoters, as promoters are known to act on specific genes in a close distance to the 
transcription initiation site.  Enhancers are generally situated at considerable distances 
from the 5’ and 3’ gene transcription sites, and from the historical view, thought to 
function independently of orientation and distance to the transcription initiation site 
(Bulger et al., 2010). 
The current estimate for the number of enhancers in the mammalian genome is 
about 1 million (Heintzman et al., 2009; Vaquerizas et al., 2009).  If the average size of 
enhancer is assumed to be approximately 100 bp in length, this would translate to a total 
combined length of 108 bp for all enhancers, which is 3.5% of the haploid mouse 
genome.  In the human genome, by this calculation enhancers make up 3% of the DNA, 
and this number exceeds the coding region size (1.5%) (IHGSC, 2001).  Therefore, the 
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critical biological role of enhancers is established from the outset.  Coupled to this, the 
identification of new regulatory elements remains a significant task to understanding 
mammalian genome regulation, especially as it relates to the complex immunoglobulin 
locus.  
One of the themes of enhancer and promoter communication is the particular cis 
relationship highlighted in this section.  Particularly, the central dogma of biology is that 
expression of genes is regulated by DNA sequences that act in cis on the same 
chromosome and respond to RNA and proteins that are encoded by genes acting in trans 
on different chromosomes.  This is supported by studies from the beta-globin locus where 
enhancers and LCRs augment the activity of promoters by interactions that consist of 
looping, which is the bringing together of distant DNA sequences into such close 
proximity that a loop forms (Chakalova et al., 2005).  Other experimental observations 
also point to trans-regulation by enhancers.  For example, in Drosophila where 
homologous chromosomes are paired in somatic cells, enhancers are associated with one 
allele can activate the promoter of a second allele in a process coined as “transvection” 
(Duncan 2002).  Even transfection assays of artificial gene constructs demonstrated that 
an enhancer can activate a promoter that is topologically unlinked, but is associated with 
either a protein bridge or located on a separate, but interlocked plasmid (Mueller-Storm et 
al., 1989).   
II. Overview of cis-Regulatory Elements:  Chromosomal Interactions
In the mammalian setting, physical and functional evidence has established non-
allelic interactions between chromosomes.  An LCR in the interferon-γ locus was shown 
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to associate with the interleukin-4 locus on a different chromosome in naïve T cells that 
are committed to differentiate into cells expressing only one of two cytokines in a mono-
allelic manner (Spilianakis et al., 2005).  Similar non-allelic interactions between 
chromosomes 7 and 11 in mice have been shown in the imprinting control region of the 
Igf2/H19 locus and the Wsb1/Nf1 gene  (Ling et al., 2006).  Lomvardas and colleagues 
have experimental evidence where a single enhancer of a murine odorant receptor (OR) 
gene cluster is able to interact with multiple OR gene promoters on different 
chromosomes, but associates with only one OR gene in any given olfactory neuron 
(Lomvardas et al., 2006).  This study suggested a mechanism that allows olfactory 
sensory neurons to choose randomly and express only one out of more than 1000 OR 
genes. 
There is also data in the human setting that proposes inter-chromosomal 
associations can form rapidly in response to extracellular cues. For example, estrogen-
inducible genes are rapidly expressed when treated with 17β-estradiol (E2). However, 
most estrogen receptor (ER-α) binding sites are intergenic and distal from E2-inducible 
genes, which suggests they form long-range looping associations (Lin et al., 2007). To 
explore this possibility, Hu and colleagues developed a novel variant of 3C technology 
termed ‘deconvolution of DNA interactions by DSL (3D) (Hu et al., 2008). Using this 
approach, they identified several intra-chromosomal associations between the E2-
regulated trefoil factor 1 (TFF1) gene on human chromosome 21 and other ER-α bound 
loci on the same chromosome. In addition, they identified an inter-chromosomal 
association between TFF1 and an E2-regulated gene, which is known to be regulated by 
estrogen in breast cancer protein (GREB1), on chromosome 2. In untreated cells these 
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associations were absent but formed rapidly (within 15 min) on treatment with E2. 
Remarkably, these associations were paralleled by re-localization of the entire nuclear 
territories of chromosome 21 and chromosome 2, which became intimately associated. 
In order to explain such cis and trans regulatory interactions between gene 
elements in different locations, a three-dimensional view of the nucleus is helpful.  For, it 
is not simply the organization of genetic elements within an individual locus that are 
critical for tissue-specific regulation, but the organization of the genome within the 
nuclear space has implications for orchestrating gene expression.  Chromatin surfaces 
again in this regards, as an accumulation of experimental evidence demonstrates that 
chromatin is folded into loops that bring regulatory elements into close contact with each 
other.  In this regard, it has been well documented that heterochromatin and euchromatin 
segregate within the nucleus, forming chromatin neighborhoods with similar properties 
(Dillon, 2004).  It has also been shown that gene-rich chromosomes are located 
preferentially towards the center of the nucleus, a feature conserved through evolution 
(Neusser et al., 2007).  Data from chromosome conformation capture (3C) studies has 
allowed analysis of chromosome folding and has revealed how promoters communicate 
with distal regulatory elements.  In mammalian cells, 3C was first used to investigate 
promoter–enhancer communication at the β-globin locus (Tolhuis et al., 2002). These 
studies revealed that, through DNA looping, hypersensitive sites within the LCR come 
into close physical proximity with the active globin genes situated 40–60 kb away, 
forming a structure called the active chromatin hub (ACH). Additional distal 
hypersensitive sites were found in close association with the LCR and active globin 
genes.  These interactions were mediated by CTCF, which is an 11-zinc-finger nuclear 
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protein that has roles in transcriptional insulation and chromatin boundary formation 
(Phillips et al., 2009).  CTCF was found to be bound to the 5’ and 3’ ends of the locus 
(Splinter et al., 2006).  The intervening sequences and olfactory receptor genes were 
looped out of this complex.  It has been suggested that the clustering of regulatory 
elements within the ACH increases the local concentration of transcription factors and 
maintains active chromatin domains, facilitating high levels of transcription (Palstra et 
al., 2008).  The presence of long range loops have been observed in other loci, including 
those of antigen receptors, and cytokines in lymphocytes (Wuerffel et al., 2007; Sekimata 
et al., 2009). 
III. Overview of cis-Regulatory Elements:  Enhancers and Gene Regulation
Given the above background, it is of particular interest for the purposes of this
thesis to study an enhancer’s ability to affect gene regulation, in terms of chromatin, 
transcription and recombination, with respect to distance.  Such a study will result in a 
more complete understanding of gene regulation.  While looping studies, using either 
ligation based methods to measure proximity between regions (3C, 4C) or direct 
microscopic visualization (3D-FISH), are helpful to analyze potential regions of 
regulation and transcription hubs, these approaches do not directly address the cis 
distance of an enhancers effect on gene regulation.  In the case of the locus control region 
(LCR) of the murine β-globin, looping results have left open the search for additional cis-
acting elements distant from target genes and then follow-up studies for how these cis-
sequences find the target gene.  In prokaryotic cells, enhancers have been reported to 
control gene regulation up to several kb (Bondarenko et al., 2003) and enhancer 
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communication for the mouse Sonic hedgehog (Shh) gene has been reported greater than 
400 kb from the transcription start site (Sagai et al., 2009).  Yet, the role of chromatin 
was not explored.  In another setting,  the human insulin (INS) locus in pancreatic islets 
on chromosome 11, which is also home to IGF2, is flanked by binding sites for CTCF 
and is part of an extensive, active chromatin domain that has marks for H3K4me2, H3ac, 
and H4ac (Mutskov and Felsenfeld. 2009).  Low levels of the inactive chromatin histone 
H3K27me3 are also detected across this domain.  Another gene, SYT8, is located 300 kb 
away on chromosome 11 and also has CTCF binding sites.  Homologues for SYT8, Syt7 
and Syt9, have been demonstrated to regulate insulin secretion in mouse islets 
(Gustavsson et al., 2008).  In the presence of glucose, both SYT8 and INS expression was 
increased and depletion of CTCF resulted in lower levels of SYT8 expression, but INS 
expression was not affected (Xu et al., 2011).  This data was corroborated with 3C 
measurements that showed an interaction between the two sites.  These results 
established the existence of a regulatory network where a cis-acting element, a promoter 
located 300 kb away from its target gene, is able to regulate expression in the presence of 
another gene, and this expression is strengthened in the presence of glucose. 
Understanding why the chromatin structure is open at INS remains to be investigated, but 
this study established a role for cis-regulatory elements to regulate gene expression and 
added support to studying whether the particular location of a cis-acting element is 
critical for its function. 
From the preceding overview, two major themes emerge for cis-regulatory 
features and their ability to alter the expression of nearby genes.  First, in regards to 
enhancers, although such mechanisms are well documented from plasmid transfection 
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assays and in textbooks (Krebs et al., 2012), it is unlikely to be explanatory in vivo 
because it fails to account for: (1) the cellular environment of genes, which includes the 
aforementioned cis-regulatory elements, and chromatin, nucleosomes, and transcription 
binding proteins, (2) the preferential bias of enhancers to initiate transcription from one 
set of promoters and not others, (3) the unknown effect of moving enhancers to different 
positions within a cellular gene, and (4) the developmentally regulated activity of 
enhancers that is likely to change based off cell differentiation status or time.  As a result, 
it is important to investigate the cis-activating effects of an enhancer in vivo, and to 
determine any changes in gene expression and chromatin as a result of moving the 
enhancer to different positions within a cellular gene.  Such an investigative study will 
either confirm the current model of enhancers established in in vitro systems, where an 
enhancer’s effect is location independent, or from the same in-vivo setting, incorporate a 
viewpoint that takes into consideration the presence of both active and silent chromatin 
histone markers and the associated promoters of these regions. 
Second, the preceding background on cis-regulating elements of the genome 
considers the emerging three-dimensional studies that regulatory elements might have the 
capacity to act in trans to affect genes on other chromosomes.  As painted by the picture 
of the above examples, the transcriptional instructions given by enhancers to promoters 
may be delivered from a different chromosome with the looping out of intervening DNA. 
Although it is likely that the nucleus is governed by self-organizing principles in regards 
to the chromatin context and transcriptional status of chromosomes, there is a wide-range 
of probabilistic intra-chromosomal and inter-chromosomal associations, and accordingly, 
further genome-wide experiments are necessary in order to achieve a complete paradigm 
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of gene regulation in mammals. Currently, experimental data is lacking that proves inter-
chromosomal gene regulation as another level of control within the nucleus, and as a 
result, the concept remains highly contentious.   
With this in view, one way to identify enhancers in the genome is by their 
sensitivity to digestion by small amounts of DNase I.  Transcriptionally active regions are 
associated with the presence of DNase I hypersensitive sites in the genome since DNA 
binding sites at these areas are more accessible to transcription factors and accessory 
proteins due to their nucleosome depletion (Gross and Garrard, 1988).  Hence, DNase I 
hypersensitivity sites (DHSs) are highly cell specific and indicate regions of open 
chromatin that regulate gene expression through binding of transcription factors 
(Sheffield et al., 2013).  A high-throughput method exists to identify DNase I 
hypersensitive sites across the entire genome using deep sequencing (Crawford et al., 
2006).  Though DNase-seq is not a substitute for ChIP-seq analysis, DNase-seq is 
valuable in identifying active enhancers and promoters that are independent of prior 
knowledge of the identity of bound transcription factors (Boyle et al., 2008).  It can be 
effectively used to inventory whole chromosomes for additional cis-regulatory elements.  
Additionally, using this technique, one way to probe for potential trans-effects of 
enhancers is then analyzing DNase hypersensitive cell types in both a wild-type and 
mutant context.  Any potential inter-chromosomal interaction will be detected by the 
presence or absence of a cluster of hypersensitive peaks in one setting and not the other.  
Such investigative studies will either add more or less experimental evidence towards the 
view that enhancers have additional inter-chromosomal gene regulation. 
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One comment must be made in regard to the inventory of enhancers across the 
genome and deriving claims for whether a particular enhancer indeed may possess inter-
chromosomal gene regulation.  All the approaches considered to this point use indirect 
properties of enhancers and do not examine whether an enhancer directly contributes to 
gene expression.  An enhancer may indeed have inter-chromosomal characteristics, but 
additional testing, such as the identification of transcription factor binding events or 
chromatin marks that are representative of function are important to actually understand 
the biological role of any inter-chromosomal relationship. 
Now that the groundwork has been laid and the various levels of regulation have 
been considered for the central cis-regulatory elements in the genome, the specific cis-
regulatory elements of the IgH locus will be explored to understand the purpose of this 
thesis. 
IV. cis-Regulatory Elements of the IgH Locus
The stage specific development and function of B-cells in the bone marrow that
results in an IgM-class immature B-cell is directly dependent on the remodeling events of 
the immunoglobulin antigen receptor loci, as these rearrangements precisely determine 
the checkpoints throughout each maturation step (Figure 1).  In turn, the cutting and 
pasting of different antigen receptor genes is a consequence of cis-acting regulatory 
elements and trans-acting factors.  While a number of cis-regulatory elements have been 
located throughout the ~3 Mb IgH locus on mouse chromosome 12, specific attention 
here will first be given to those significant elements within the 270 kb DH to CH region, 
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followed by a selection of elements elsewhere on the IgH locus, as the pro-B cells 
prepare for IgH V(D)J recombination (Figure 5). 
Two major cis-regulatory elements are currently known to exist within the DH to 
CH region on the IgH locus that are marked by lineage-specific DNase I hypersensitive 
sites.  This includes the most 3’ D-gene segment, DQ52, which has both promoter and 
enhancer activity (Kottmann et al., 1994), and the 700-bp Eµ intronic enhancer that is 3’ 
of the last J-gene segment.  The overview here will start with those cis-regulatory 
features of DQ52 promoter, known as PDQ52, and its flanking gene partner, DFL16.1, and 
their role in gene regulation as it relates to chromatin, transcription, and recombination. 
Initial chromatin analysis on the IgH locus in pro-B cells demonstrated a tissue-
specific restricted and patterned environment for histone acetylation to the DH to CH 
region and not to the VH genes (Morshead et al., 2003).  Even the chromatin mark 
H3K4me3, which is a footprint for active promoters, demonstrated little enrichment in 
the V region with several peaks of enrichment in intergenic regions (Malin et al., 2010).  
Therefore, the specific architecture of active and inactive chromatin marks in the DH to 
CH region is unique, insofar as it points to a functional developmental significance for this 
area in mouse pro-B cells.   The character of these active histone marks H3K9ac and 
H3K4me3 were found to be further restricted to nucleosomes of the outermost 5’ and 3’ 
genes, DFL16.1 (chromosome 12:114,720,388) and DQ52 (chromosome 12: 
114,668,722), respectively (Chakraborty et al., 2007) (Figure 6).   These two genes are 
separated by a distance of ~52 kb that contains the D-gene family.  All D-genes between 
these boundaries share a high degree of homology within a repeated 4 kb sequence and 
are known as the DSP gene segments.  This intervening region is masked with H3K9me2 
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heterochromatin marks (Bolland et al., 2007; Chakraborty et al., 2007).  While the two 
flanking genes, DFL16.1 and DQ52, were most sensitive to DNase I digestion, the 
intervening segments were insensitive.  In addition, the active chromatin pattern at DQ52 
has a dramatic increase in both H3K9ac and H3K4me3 less than 1 kb 5’ from the JH 
cluster of genes in pro-B cells (Chakraborty et al., 2009).  This hierarchal pattern that has 
specific boundaries of active chromatin peaks followed by a dramatic elevation in the JH 
family is significant since it points to locations where the RAG nuclease likely prefers 
association to prepare and initiate V(D)J rearrangement events on the IgH locus. 
Connected to this, upon targeted deletion of the JH gene segment, direct VH to DH 
rearrangement is not observed (Chen et al., 1993).  Therefore, the chromatin picture is 
instructive for how the complex process of RAG-mediated rearrangements take place.  
Even within the overall paradigm of VH to DJH rearrangement, a VH gene segment must 
overcome the intervening heterochromatic-dominated DH segments to join a recombined 
DJH segment.  This raises questions about the outermost DH gene, DFL16.1, which 
displays active chromatin marks and transcription characteristics and appears to function 
like a castle’s most exterior wall that guards the king and queen inside its gates.  
Technically though, DFL16.1 is not the outermost DH gene, as this distinction belongs to 
DST4.2, which is located 43 kb upstream of DFL16.1 and although it has an RSS 
sequence, it’s never been observed to have undergone D to J rearrangement and also no 
transcripts have been reported from this site (Featherstone et al., 2010; Ye J., 2004).  
Returning to DFL16.1, this gene has a bidirectional promoter and its transcript level 
compares to DSP2, and when compared to its flanking partner, the level is about 50% of 
DQ52 (Chakraborty et al., 2007).  Because of DFL16.1’s isolated position, several 
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studies have led to speculations that the VH – D intergenic region contains additional cis-
regulatory elements and that DFL16.1 marks a chromatin boundary. 
In the first study, a distal VH gene was relocated several megabases and placed 1 
kb 5’ of DFL16.1 in pro-B cells (Bates et al., 2007).  Interestingly, the relocated VH gene 
underwent direct rearrangement to unrearranged DH gene segments.  This led to the 
conclusion that the chromosomal location of a VH gene is the determining factor as to 
whether it’s used or not for V(D)J recombination.  Also, it was thought that there may be 
a cis-regulatory element in the VH-D intergenic region that was able to influence VH to 
DJH recombination (Bates et al., 2007).  In a second study, a germline mutation was made 
in mice that removed the whole 100 kb intergenic region between VH81X and DFL16.1 
and placed VHQ52.2.4 adjacent to the DH locus (Giallourakis et al., 2010).  This 
configuration of the locus led to elevated levels of antisense D transcripts that started 
within the D locus and went upstream through the D locus and continued until 
VHQ52.2.4.  This antisense transcription was reflected by an increase in D to JH 
rearrangement and proximal VH to DJH gene recombination in T cells.  This result led the 
authors to conclude that the deletion of the intergenic region removed a negative element, 
specifically two insulators, which act to suppress anti-sense D transcription.  By 
removing these insulators and physically placing the VH gene next to the D genes, it 
triggered antisense DH transcription which resulted in activate rearrangement of DH to VH 
genes (Giallourakis et al., 2010).  This was supported by the identification of an 
assemblage of three DNase hypersensitivity sites that were located near DFL16.1 and 
have been shown to have an insulator sequence that contains CTCF-binding elements 
(Featherstone et al., 2010) (Figure 5).  The purpose of this sequence (CCCTC) is to serve 
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as a barrier element to recombination and prevent spurious germline rearrangements 
between VH, DH, and JH gene segments.  Collectively, these three studies pointed to 
additional cis-acting elements directly upstream of DFL16.1 that will be discussed further 
below. 
Opposite of DFL16.1 on the 3’ end in the DH domain is DQ52.  Non-coding RNA 
transcription on the germline allele, also called sterile transcription, from the DQ52 
promoter, PDQ52, reflects in part the active chromatin status of this gene in pro-B cells.  
The promoter PDQ52 becomes active prior to the initial D to JH recombination event and 
initiates the µ0 transcript (Alessandrini, A., and Desiderio, 1991).  This transcript is 
directed away from the JH and Cµ exons in the antisense orientation and gets spliced to 
the JH1 splice donor site (Schlissel et al., 1991; Chakraborty et al., 2007).  After D to J 
rearrangement, the DJ joined segment produces Dµ transcripts, which is followed by 
non-coding RNA transcription in the VH locus (Reth and Alt, 1984; Yancopoulos and 
Alt, 1985; Corcoran et al., 1998).  Every DH gene segment that is located upstream of 
DQ52 has a bi-directional promoter, where at D to JH rearrangement, are activated to 
produce both a sense and antisense transcript towards and away from the Cµ exon.  The 
anti-sense transcript level decreases rapidly in a distance-dependent manner and the sense 
transcript is spliced so that the rearranged DJH segment is joined to the Cµ exon.  
The accumulation of evidence and patterns from active chromatin marks and 
transcription generation from the PDQ52 promoter has the functional consequence of 
preference for specific D to JH gene rearrangement over others, as DQ52 to JH 
recombination takes place at a higher frequency than the intervening DSP gene segments.  
Though higher than the DSPs, some studies accounted for DFL16.1 being used at even a 
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higher frequency than DQ52 in mature B cells (Chang et al., 1992; Tsukada et al., 1990).  
Although these analyses were executed in mature B cells that may have already had 
secondary rearrangements or other chromatin based mechanisms of preference selection 
towards the flanking DQ52 and DFL16.1 flanking genes, analysis in pro-B cells has 
confirmed the preference for these outer segments in rearrangements and also similar 
usage levels (Tsukada et al., 1990).  As a result of these rearrangement preferences, the 
best mode of interpretation for these choices is that these outer-gene segments, due to 
their active chromatin marks, especially H3K4me3, are most accessible to recombinase in 
pro-B cells (Figure 6).  This conclusion is corroborated with data on four levels that serve 
to explain the constraints for ordered V(D)J rearrangement.  First, the presence of active 
histone marks in a distinguishable pattern, and the lack of these marks in VH genes 
explains why the initial rearrangement takes place between DH to JH genes and excludes 
VH genes. The low enrichment of active histone marks on VH genes in pro-B cells renders 
them inaccessible to RAG (Chowdhury, D. and Sen, R., 2001). 
Second, it is the JH region that has the highest level of RAG proteins in the IgH 
locus at the pro-B cell stage, as RAG is not detectable in VH gene segments (Ji et al., 
2010; Subrahmanyam et al., 2012) (Figure 6).  Consequently, there is not simply a 
preference for a patterned chromatin landscape in pro-B cells, but this pattern provides 
focal establishment of recombination centers that give direct accessibility for RAG to 
carry out the gene rearrangement in a precise manner.  To further explain the preference 
for certain DH gene segments over others, a special spatial configuration has been 
observed where the 3’ domain of the IgH locus undergoes a conformation change and 
compacts as it folds into a three-loop structure that locates the flanking DH gene segments 
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in close proximity to the RAG-bound recombination centers (Guo et al., 2011).  Such a 
looping structure explains why the flanking DH gene segments are used at a higher 
frequency than the intervening segments, for the DH-associated RSSs are brought into 
close proximity at the initial D to JH rearrangement step.  Taken altogether, the enhancer 
and promoter activities of the cis-regulatory element PDQ52 to generate the µ0 transcript, 
including the specific active chromatin boundaries of the flanking DFL16.1 and DQ52 
genes, along with the increase in these marks in the JH  gene segments, and the spatial 
conformation of these flanking DH gene segments to the recombination center, helps to 
explain their higher usage for recombination frequency, the precise localization of RAG 
to this area on the IgH locus, and ability to govern the initial D to JH rearrangement step.   
The functional consequence of this paradigm is that the intervening DSP gene 
segments recombine less frequently, and this can be explained on two basic levels.  First, 
these gene segments are dominated by heterochromatin marks that make RAG 
inaccessible, as RAG binding is specific to H3K4me3 (Figure 6).  Second, according to 
the dynamic looping model of the 3’ IgH locus, the DSP gene segments are further away 
from the recombination center, and therefore are not used as much in gene 
rearrangements as the flanking regions.  The DSP gene segments are still used in 
rearrangements, but at much lower frequency and only when the dynamic looping allows 
a transient movement of the loop such that the RSSs of specific DSP gene segments are 
brought near the RAG recombination center in the JH cluster.  Yet, in order to precisely 
explain the impact of cis-regulation on the IgH locus, the critical significance of the Eµ 
enhancer and its role in gene regulation must be outlined.  Deletion studies from DQ52 
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provided an important clue for the significance of the Eµ enhancer and later studies 
affirmed its vital role in IgH rearrangements in pro-B cells. 
One important investigation implemented a targeted mutation in the PDQ52 
promoter.  No significant impact on D to JH rearrangement was observed in pro-B cells 
and µ0 transcripts were still detected (Afshar et al., 2006, Nitschke et al., 2001).  This 
suggested that the heterologous PDQ52 promoter was not completely diminished in this 
context.  Yet, these studies were significant because it pointed to an element outside of 
DQ52 that is responsible for initial D to JH rearrangement gene rearrangement.  When 
investigators replaced the 700-bp Eµ intronic enhancer cis-regulatory element 
(chr12:114,665,501 - 114,666,175) with a phosphoglycerate kinase promoter – neomycin 
resistant gene cassette (PGK-NeoR), it resulted in complete inhibition of both µ0 
transcripts and D to JH rearrangement (Perlot et al., 2005).  Even removal of the 220 bp 
core region of the Eµ enhancer resulted in a significant reduction in D to JH (Perlot et al., 
2005; Chakraborty et al., 2009).  When both the PDQ52 promoter and the full 700 bp Eµ 
enhancer are deleted, the results are similar to the deletion of the 220 bp core region of 
the Eµ enhancer (Afshar et al., 2006).  Therefore, DQ52 is dependent on the Eµ enhancer 
and this was substantiated by a critical DNase hypersensitivity experiment, which showed 
that when the core of the Eµ enhancer is deleted, the hypersensitivity peak at DQ52 is 
also removed (Chakraborty et al., 2009).  Collectively, these results have pointed to the 
critical role for the cis-regulatory Eµ intronic enhancer in activating the IgH locus for 
gene recombination in B-cell development.  The significance of this enhancer is further 
demonstrated from chromatin and transcription analysis (Chakraborty et al., 2009; 
Chakraborty et al., 2007). 
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At the level of chromatin, the effect of the Eµ enhancer to the DH to CH region has 
a unique pattern that is distinguished from the pattern noted previously for DQ52 
DFL16.1 genes (Figure 6).  This effect was explored by deleting the 220 bp “Eµ core” in 
pro-B cells (Chakraborty et al., 2009).  While the flanking D-gene segments have the 
active chromatin marks that are then sandwiched by a distance of 52 kilobases (kb) of 
intervening heterochromatin, there is a specific cluster of active acetylation marks present 
in the JH genes that is significantly diminished in the absence of the Eµ core (Chakraborty 
et al., 2009).  This reduction in active marks is complemented with an increase in inactive 
marks; specifically, there is a significant increase in H3K9me2 at the JH gene cluster in 
the Eµ-core deleted setting.  There is also a reduction in H3K9ac and H3K4me3 
throughout the DH to CH region.  This observation includes a major lowering of active 
chromatin marks at both DFL16.1 and DQ52 in the deleted Eµ core setting and as far as 
15 kb downstream of the Eµ enhancer.  Nonetheless, not all areas in this region of the 
IgH locus appeared Eµ dependent.  In the deleted Eµ core setting, there was less 
reduction observed between DQ52 and JH4 for H3K4me2, and the gene region between 
DQ52 and Cµ had a comparatively reduced level H3K9me2 regardless of whether Eµ is 
present or absent.  Such data indicated there are Eµ dependent and Eµ independent events 
as the IgH gene segments prepare for rearrangement (Chakraborty et al., 2009).  
Regulation of these independent events are likely attributed to other cis-acting elements 
on the IgH locus that are further explored below.  In view of the Eµ dependent chromatin 
changes between the DH to CH region of the IgH locus, the key conclusions from this 
pioneering chromatin study were twofold.  First, deletion of the Eµ core acted locally to 
affect the chromatin structure of genes in the JH cluster that are between 650 bp and 2 kb 
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away, and as a result, the heightened elevation of histone acetylation and H3K4me3 over 
the JH cluster is Eµ dependent.   Second, deletion of the Eµ core led to the reduction of 
chromatin at genes 3 kb (DQ52) and 54 kb (DFL16.1) upstream and 15 kb downstream.  
As a result, insofar as the histone marks for H3K9me2, H3K9ac, and H3K4me3, the Eµ 
core had an effect that was both local, extending a total distance of 69 kb with respect to 
the chromatin landscape.  The importance of this chromatin view is that euchromatin is 
limited to distinct regions that are controlled by the Eµ enhancer, and this paradigm then 
limits the regions of RAG binding, thereby restricting the preparation and initiation of DH 
to JH gene rearrangement in pro-B cells.  In order to initiate the dynamic chromatin 
changes in pro-B cells for gene rearrangements, may be the role of putative “pioneering 
factors,” perhaps noncoding RNAs that are known to modulate histone tails, which 
initiate intergenic transcription within silent chromatin and such transcription then 
promotes histone exchange for active modifications (Mito et al., 2005; Orphanides and 
Reinberg, 2000). Transcription at the Eµ enhancer is then critical to the ordered process 
of gene rearrangement events in pro-B cells as it reflects, in part, the chromatin features. 
Although the Eµ enhancer functions as the promoter for Iµ sterile transcription of 
non-coding RNA in germline alleles (also termed iEµ), and this has been restricted to the 
700 bp sequence between XbaI and EcoRI in the JH and Cµ area of the IgH locus, it is the 
220 bp Eµ core where the majority of binding sites for transcription factors exist 
(Nikolajczyk et al., 1999; Su and Kadesch, 1990).   This Eµ core is surrounded on each 
side with matrix attachment regions (MARs) that have yet to demonstrate any role in 
transcription or recombination (Jenuwein et al., 1997; Sakai et al., 1999).  At the level of 
transcription, deletion of the 700 bp Eµ, including its core and MARs, produced results 
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that demonstrate its primary role as a cis-regulatory element.  While antisense intergenic 
transcription occurs throughout the DH and JH gene clusters prior to recombination, 
deletion of Eµ resulted in loss of iEµ and D antisense transcription over a 60 kb region of 
DH segments (Afshar et al., 2006; Bolland et al., 2007).  This result supported the role of 
Eµ as the regulator for D-J rearrangements by its ability to activate antisense transcription 
through the D domain.  The Eµ enhancer has also been recognized to have ongoing 
transcription throughout V(D)J rearrangements in both pro-B cells and B-cell 
development in the bone marrow (Bolland et al., 2004; Osborne et al., 2007).  In this 
regard, the non-coding Eµ enhancer has been suggested to be the first “super-intergene” 
ever found (Fraser, 2006; Matheson and Corcoran, 2012).  For, it has all the dressings of 
a significant cis-regulatory element with its featured MARs, core transcription factor 
binding region, and precise location adjacent to the indispensable JH gene family.   
All of these transcription roles were further refined in the deleted Eµ core context 
(Chakraborty et al., 2009), where germline transcription was observed to affect VH genes 
up to 450 kb upstream.  However, as mentioned earlier, these same VH genes bear no 
marks for either H3K4me3 or H3K9ac, suggesting that transcription at these gene 
promoters is not under the control of epigenetic regulation.  Also in the deleted Eµ core 
setting, all transcripts in the Cµ area were reduced by approximately 7-10 fold and DH 
amplicons were also reduced, but in a much higher amount (~10-50 fold).  Alongside 
this, RNA polymerase II binding was also significantly reduced.  Hence, the transcription 
studies on the deleted Eµ core demonstrate that one function of Eµ is to attract RNA 
polymerase II in the presence of the open chromatin context.  Second, the Eµ enhancer 
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has specific and selective transcription targets in the DH to CH region that is related to the 
chromatin structure, but is not epigenetically related in the VH region. 
The pattern between open chromatin and transcription in the DH to CH region is 
also supported by DNase I digestion experiments with one caveat.  In Eµ sufficient pro-B 
cells, the flanking DH genes DFL16.1 and DQ52 demonstrate DNase I sensitivity while 
the intervening region is insensitive.  Rapid degradation of amplicons is also observed in 
the 7.8 kb region that is between DQ52 and Cµ, which is indicative of DNase I 
sensitivity.  These patterns of sensitivity are reflective of the unique chromatin structure, 
and parallels the heightened presence of H3K4me3 marks in comparison to the rest of the 
locus.  Yet, in the deleted Eµ core model, there is minimal degradation at DFL16.1 
(Chakraborty et al., 2009).  The most likely explanation of this phenomenon is that 
DFL16.1 is regulated by other cis-regulatory elements in addition to the Eµ enhancer as 
the IgH locus prepares for gene rearrangement.  Such regions may include the IgH 3’RR, 
a 40 kb long regulatory region located downstream of Cα, and potential cis-regulatory 
elements within the 5’ V region of the IgH locus (Figure 5).  
The IgH 3’RR was initially identified by the presence of a DNA sequence that 
had B-cell specific enhancer characteristics located ~25 kb downstream of the most 3’ CH 
genes, Cα (Pettersson et al., 1990).  Several additional enhancers were identified by the 
presence of DNase I hypersensitive sites and the activity of these enhancers were 
typically confirmed in transient transfection assays using B cell lines that reflected 
different stages in B-cell development (Michaelson et al., 1995).  In total, four enhancers 
(hs3a, hs1.2, hsb, and hs4) and four additional DNase I hypersensitive sites were 
identified, known as hs5-8 (Garrett et al., 2005) (Figure 5).  One special feature of hs5-8 
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is that it contains a CTCF/Pax5 binding region (Chatterjee et al., 2011).  As a result, the 
IgH 3’RR contains two related, but distinct segments.  The first is the ~28 kb region 
consisting of the four enhancers, and the second is the ~12 kb region.  Experimental 
analysis of targeted mutations in mice from several labs demonstrated that the IgH 3’RR 
enhancers are critical for somatic hypermutation and class switch recombination, but not 
for V(D)J joining (Rouaud et al., 2012).  Likewise, mild phenotypic changes were also 
observed when an 8 kb region of the hs5-7 CTCF/Pax5 sites were deleted (Volpi et al., 
2012).  The lack of any major changes in deleting portions of the 3’RR might be 
attributed to the presence of hs8, which contains two CTCF sites and was not included in 
the hs5-7 deletion studies.  Therefore, future deletion studies that include hs8 may indeed 
reveal a greater regulatory role for V(D)J recombination. 
While deletion studies have not revealed a significant role for the 3’RR with 
respect to V(D)J recombination, 3C studies in MPC11 plasma cells, variant and normal 
splenic B cells, and resting B cells have shown that the 3’RR does interact with the JH - 
Eµ region in both Eµ sufficient and Eµ deficient cells (Ju et al., 2007; Wuerffel et al., 
2007).  This interaction may explain the Eµ independent events that are observed with 
respect to H3K4me2 and H3K9me2 in the DQ52 to Cµ region of the IgH locus.  In this 
model, the 3’RR has two roles.  First it leads to demethylation of H3K9me2, and second, 
the 3’RR delivers the histone acetyltransferases to the H3K4me2 marked promoter for 
transcription initiation, which results in H3K4me3 histone modifications and an 
accessible state for recombinase.  The meaning of this interaction between the 3’RR and 
IgH locus is likely predicated on the location of CTCF sites on the IgH locus.  Such sites 
have been located in two places: (1) 3.1 and 5.7 kilobases 5’ of DFL16.1, known as the 
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IGCR1, and (2) several locations in the VH region (Ebert et al., 2011; Featherstone et al., 
2010; Guo et al., 2011).  Of particular importance, it has been demonstrated that the 
insulator 3’RR CTCF/Pax5 hs5-8 binding region interacts with the DFL16.1 proximal 5’ 
CTCF sites (IGCR1) (Guo et al., 2011).  Although deletion of the IGCR1 demonstrated a 
key role for the IGCR1 in terms of the balance between proximal and distal VH
rearrangements, it is not required for overall VH to DJH recombination (Guo et al., 2011).  
A future study that deletes both the IGCR1 and the 3’RR may yield a larger defect in VH 
to DJH rearrangements, however the initial D to JH recombination event is unlikely to be 
affected.   
Consequently, the exact role of these cis-regulatory elements, 3’RR and the 
IGCR1, and how they relate to DFL16.1 and other events in pro-B cells, remains unclear.  
These regions are likely interacting to prepare the IgH locus in pro-B cells for gene 
recombination and assist in the control of other events in B-cell development and 
maturation.  Chromatin looping studies have demonstrated the IgH domain undergoes 
contraction and decontraction events to influence partner selection in developing B cells 
for gene recombination.   In pro-B cells, the IgH locus contracts to bring the separate 
gene clusters close together for VH to DJH recombination.  This contraction is followed by 
a locus decontraction at the next stage of development to prevent rearrangements on the 
second allele.  Several labs have used chromosome capture studies (3C and 4C) to view 
several large-scale contraction phenomena in pro-B cells (Guo et al., 2011; Medvedovic 
et al., 2013; Sexton et al., 2009; Zhao et al., 2006).  These investigations have 
demonstrated several important features regarding flexible long-range interactions 
between cis-regulatory components on the IgH locus.  First, interactions have been 
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demonstrated between the 3’RR and VH genes in Rag-/- pro-B cells prior to V(D)J 
joining (Medvedovic et al., 2013).  These communications we’re found to depend on 
Pax5, YY1, and CTCF.  Interestingly, such an interaction might indeed be a preparatory 
feature of the IgH locus in pro-B cells as it is maintained when cis-regulatory features, 
such as Eµ, IGCR1, and portions of the 3’RR are deleted.   
Several other interactions between cis-acting elements that correspond to CTCF 
bound VH sites have been found in the 5’ VH region (Guo et al., 2011).  These loops are 
reported to extend between 30-500 kb between different VH regions, and even one set of 
loops associates with DFL16.1 in an Eµ independent manner.  This may explain how the 
mild hypersensitivity peak at DFL16.1 is maintained in Eµ deficient pro-B cells and also 
the preference for DFL16.1 rearrangements with proximal VH gene segments (Perlot et 
al., 2005).  Taken altogether, the IgH locus then positions itself early in pro-B cells for 
the main recombination event, and there is an organization within the locus that is 
broadly maintained independent of the cis-acting elements, including Eµ. 
Second, when JHT-/- Rag2-/- Eµ-/- pro-B cells are compared to Rag2-/- pro-B 
cells with respect to locus contraction, a significant role for the Eµ enhancer is observed 
at the 3’ proximal end of the locus.  In this setting, the dynamic folding of the locus is 
dependent on Eµ as it interacts with the VH region, several kb 5’ of DFL16.1, and also 
with the 3’RR (Guo et al., 2011).  The Eµ enhancer was described as the critical cis-
regulatory element that forced the three-dimensional structure into its unique fold for 
V(D)J recombination.  Therefore, the Eµ cis-regulatory element is then able to position 
segments of the IgH locus to a nuclear environment that is accessible to transcription 
factories, including RAG recombinase.   
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Given the need for stable proximity of the locus during gene rearrangements, 
ncRNAs have been suggested as a mechanism that modulates the folding of V, D, and J 
gene segments so that the V chromatin domains interact with the DJ cluster at precisely 
the correct time (Matheson and Corcoran, 2012; Jhunjhunwala et al., 2009).  Noncoding 
RNAs are known to nucleate structure.  MARs are known to bind proteins associated 
with repression and activation and have also been established as organizers that maintain 
chromatin into loops to keep the associated DNA with the nuclear matrix.  MARs flank 
the core of the Eµ enhancer and are also deposited at many places throughout the VH 
region.  In this model, Eµ through its MARS, recruits the D and J gene segments into a 
nuclear space that is favorable for D to JH recombination, and also where non-coding 
RNA transcription takes place to allow the non-coding V region to associate with the 
transcription factory to enable V to DJH joining.  In summary, herein lies the pivotal role 
for Eµ enhancer: control the DH to JH chromatin landscape to initiate site specific IgH 
gene rearrangement for optimal production of a function B-cell receptor.  
Other cis-regulatory features may be present in the VH domain of the IgH locus 
(Figure 5).  This comes from the recognition that the 5’ VH cluster is not deleted during 
the process of V(D)J recombination.  Interactions through radial repositioning between 
the VH domain and other regions of the IgH locus are likely necessary for accessibility 
control, allelic exclusion, and the temporal positioning of RAG nuclease during B-cell 
development and maturation.  One of the initial lines of evidence that supported this view 
was the identification of several DNase I hypersensitive peaks centered around Zfp386, a 
Kruppel-like zinc finger protein, located 30 kb upstream of the last 5’ VH  gene 
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(Pawlitzky et al., 2006).   Further analysis on this site featured no relationship to allelic 
exclusion or gene recombination. 
Another line of evidence for cis-acting elements in the VH gene segment comes 
from the presence of Pax5 binding sites in this region (Ebert et al., 2011; Zhang et al., 
2006).  Although Pax5-/- mice have no major defects in any of the ordered recombination 
steps in developing B cells (Hesslein et al., 2003; Nutt et al., 1997), Pax5 may direct 
RAG recombinase to many areas in the VH domain, including the VH3609 gene family 
(Ebert et al., 2011; Subrahmanyam and Sen, 2012).  These Pax5 binding sites also bind a 
collection of proteins all implicated in DNA looping in pro-B cells: CTCF, E2A, YY1 
and Rad21, an integral subunit of the cohesin complex.  These conserved binding sites 
have been called “PAIR” elements (Pax5-associated intergenic repeat) (Ebert et al., 
2013).  PAIR elements have been identified in 14 locations, and 11 of these are upstream 
of VH3609 in the distal VH domain.  These cis-acting elements have been shown to 
operate as promoters and give rise to anti-sense transcription in pro-B cells.  Due to their 
location in the distal VH region, they have been implicated in Pax5 dependent IgH 
contraction and VH to DJH rearrangements. 
In conclusion, this sub-section has highlighted the significant role of cis-acting 
elements as they have been described in the genome and also those that are specific to the 
IgH locus.  Particular focus was given to the β-globin locus LCR, numerous interactions 
reported between cis-elements and other chromosomes, and the human insulin locus was 
highlighted to demonstrate cis-regulation of a gene at a considerable distance due to the 
chromatin pattern.  However, many questions for these cis-regulatory components of the 
genome remain, as several studies have left open roles for other cis-acting factors that 
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further explain the in vivo interaction.  Next, the significant cis-regulatory features of the 
IgH locus were described.  While many elements have been identified, and all likely have 
a role in B-cell development that need further exploration, the Eµ enhancer was 
demonstrated to have distinct features in regulating chromatin, transcription, and 
recombination.  Although the Eµ enhancer has a definite critical role in D to JH gene 
rearrangements in pro-B cells, it is important to study whether the Eµ enhancer has gene 
regulatory features that extend beyond its proximal domain and into other areas of the 
genome.  Moreover, the specific characteristics of the Eµ enhancer lead to the 
consideration of whether or not this enhancer retains its cis-regulatory function as it 
relates to the D-JH domain of the IgH locus when it is moved to other areas in the IgH 
locus.  The central prediction from in vitro transfections assays is that the enhancer will 
retain its ability to regulate gene expression regardless of distance from their promoters. 
Both projects in this thesis will study these hypotheses and test whether the Eµ enhancer 
affects other genes within and beyond its proximal domain, and if the Eµ enhancer retains 
its cis-regulatory characteristics, with respect to chromatin, transcription and 
recombination, when it is relocated to other regions in the IgH locus.  In this regard, two 
brief sub-sections follow that describe the background for key experiments used in this 
thesis to test both the relation of the Eµ enhancer’s location to gene regulation, and 
whether the Eµ enhancer affects other genes beyond the D to JH region. 
V. Use of Bacterial Artificial Chromosomes to study cis-regulatory features of 
the IgH locus 
One major goal in developmental biology is to study tissue-specific regulatory 
elements within their native context.  Prior to the Human Genome Project, most 
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functional studies to investigate gene regulatory elements were accomplished by sub-
cloning small fragments of genomic DNA into various reporter vectors.  This included 
transfection assays, where different combinations of cis-regulatory elements were 
inserted into plasmids and used for transfection assays to study the transcriptional effects 
of a given set of regulatory elements on a gene of interest.  Using such methods, 
enhancers were originally defined as a region of DNA that is able to activate transcription 
from a target promoter in both a location and orientation independent manner (Banerji et 
al., 1983; Gillies et al., 1983).  In fact the Eµ intronic enhancer was initially discovered as 
a transcriptional enhancer in this way, as it was observed to drive the expression of 
immunoglobulin or other transgenes in an orientation and position independent manner in 
lymphoid cells alone (Banerji et al. 1983; Gilles et al., 1983; Neuberger 1983). Yet, it has 
been increasingly clear that studying a tissue-specific enhancer outside of its natural 
context in transgenic reporter assays may not reflect the intrinsic character of that cis-
regulatory element in its own natural genetic environment (Chatterjee et al., 2012).  
Bacterial artificial chromosomes (BACs) overcome this defect as they may be 
used to study regulatory elements located distantly from a gene.  BACs are single copy 
replicons originated from the naturally occurring Escherichia Coli fertility plasmid (F-) 
and were first developed as large insert clones to assist in the construction of a consistent 
set of overlapping clones for the Human Genome Project (Shizuya et al., 1992).  Due to 
their large insert capacity, ranging from 100-750 kb of genomic sequence, BACs are able 
to be comprised of whole genes and the necessary cis-regulatory elements, and at the 
same time be flanked by regulatory DNA elements that provide the signals needed for 
correct spatio-temporal gene expression (Antoch et al., 1997;  Sharan et al., 2009; Valjent 
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et al., 2009).  In addition, BAC transgenes are able to mimic the natural expression of the 
gene(s) of interest to a much higher degree than conventional transgenes (Gong et al., 
2003; Yang et al., 1997).  The original basis for using BACs to study genome structure 
and function came from a mouse study where a ~100 kb construct was introduced into 
the germline of a mouse and demonstrated the expected tissue-specific expression pattern 
(Kim et al., 1996).  Along with this, BACs are able to be used to study the developmental 
consequence of accurate but excess expression of genes.  One critical feature of BACs is 
their ease of manipulation, and therefore, not only can the expression of genes be studied, 
but the deletion, modification, or insertion of different cis-regulatory elements allows 
BACs to be used as means to study mechanistic and functional questions.  Therefore, 
BACs represent an ideal tool to study the manipulation of cis-regulatory sequences within 
the native genome environment, and thereby allows further investigation about cis-
regulatory features that cannot be detected in in-vitro transfection assays.  With respect to 
the Eµ enhancer, BAC sequences are able to be manipulated so that, while keeping the Ig 
DH and JH locus intact, the location of the Eµ enhancer may be different from the 
endogenous position.   This system sets up the experimental investigation as to whether 
the Eµ enhancer is able to regulate genes at different locations as it does in the 
endogenous setting. 
VI. Cis-regulatory elements and probing for other interactions
One of the main mechanisms that determine tissue specific patterns of genome
organization is the regulation of differential gene expression.  In complex genomes, cis-
regulatory elements are distributed in a variety of intergenic and intragenic locations that 
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are hundreds of kilobases away from their target genes (Nobrega et al., 2003).  The 
purpose of these cis-acting elements is to fine tune the expression of genes in a cell-type 
specific manner.  Enhancers are one of the significant cis-acting elements that control 
tissue specific gene expression.  Essentially, they are the main drivers of gene expression. 
Enhancers recruit transcription factors that in turn disrupt histone continuity and establish 
nucleosome-depleted regions that further attract ATP-dependent chromatin remodeling 
complexes to open the chromatin structure for enhancer coordinated gene function.  
Genome-wide mapping data on nucleosome occupancy indicates that at cis-regulatory 
elements, such histone replacement closely reflects the presence of nuclease-
hypersensitive sites (Mito et al., 2007).  As the key that unlocks the door of gene 
regulation, the ability for any enhancer to affect other cis-regulatory elements in 
intergenic or intragenic regions may be probed by their sensitivity to minimal amounts of 
DNase I digestion.   
X-ray structural analyses of DNase I complexes showed the protein binds only to 
the minor groove and the backbone phosphate group to cleave the sequence in neither a 
sequence nor base-specific manner (Suck, 1994).  There is no contact between DNase I 
and the major groove of right handed DNA duplexes.  Such binding of DNase I then 
alters the conformation of the groove geometry and distorts the B-DNA conformation 
(Lahm and Suck, 1991; Weston et al. 1992).  The cutting rate of DNase I is sequence 
dependent and the cleavage probabilities are low where a string of As and Ts are present 
and also in GC rich areas (Suck, 1994).   
Originally isolated from bovine pancreas by Kunitz in 1940, the DNase I gene is 
located on mouse chromosome 16 at position 4,037,101-4,040,024.  Spanning nearly 3 kb 
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of DNA, the gene consists of eight introns and eight exons (Peitsch et al., 1995).  It is 
ubiquitously expressed in mammalian tissues and has many roles, including the removal 
of DNA from nuclear antigens (Oliveri et al., 2004).  Mice that are deficient in DNase I 
demonstrate autoimmune characteristics.  It also operates as a transcription factor that is 
implicated in Fas expression on the cell surface in human cells (Oliveri et al., 2004). 
When used as a structural probe to map regulatory DNA, the DNase I digested fragment 
length parallels transcription factor occupancy (Lazarovici et al., 2013).  Nucleosome 
depleted DNA that has bound regulatory factors is more accessible to the DNase 
endonuclease compared to nearby condensed chromatin that is wrapped twice around a 
core of four histone pairs.  It is this accessibility that marks the hypersensitive sites of a 
DNA sequence for DNase I digestion.  Cleavage takes place at nucleotides that are free of 
proteins.  It is precisely by this means that cis-regulatory elements, such as enhancers, 
can be interrogated and epigenetically marked.  One distinguishing feature of chromatin 
accessibility is the presence multiple DNase-I cleavage sites within a short distance when 
the enzyme is used on intact nuclei.  Therefore, when minimal genome cutting takes 
place in the presence of the non-specific endonuclease (1%), a systematic picture of the 
cis-regulatory features of the genome emerges.  In this framework, regions of the genome 
that have enhancer-like properties may be inventoried, and even other areas an enhancer 
may affect within or outside a chromosome can be investigated.  As a result, this tool can 
be used with the Eµ enhancer to probe for other sites of potential regulation, which will 
be further described below. 
Transition Remarks  
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From the above analysis, several conclusions may be drawn concerning the cis-
regulatory elements on the IgH locus that set up the projects for this thesis.  First, the 
discovery of the Eµ enhancer in transfection assays did not consider the complex cellular 
environment of multiple cis-regulatory elements that interact to control gene regulation 
(Banerji et al., 1983; Gillies et al., 1983).  For over thirty years, the study of enhancers 
that takes into consideration the in vivo chromatin environment, other cis-elements, and 
an enhancer’s location has been difficult due to the lack of technology to probe this 
relationship.  Although enhancers were classically defined as cis-regulatory elements that 
are able to activate transcription independent of location and distance, it has not been 
tested in an in vivo setting whether this definition remains suitable.  BACs provide a tool 
to express long stretches of gene domains in mice and examine whether enhancers retain 
their cis-acting characteristics independent of distance and location.  Specifically, BACs 
allow an enhancer to be moved into a region dominated by heterochromatin to study 
whether an enhancer is able to open the nearby chromatin structure and active gene 
transcription.  In addition, BACs allow an enhancer to be placed a considerable distance 
from their endogenous site to determine whether their gene regulatory features are the 
same or different.  The prediction from in vitro plasmid transfection assays is that an 
enhancer will be able to have the same gene regulatory features independent of distance 
from the endogenous site in an in vivo setting.  Chromatin domains were not in view in 
the original transfection assays, but BACs allow the definition of an enhancer to be 
further modified to more closely represent an enhancer’s endogenous context.   
Alongside this, the tissue specific nature of enhancers may be studied using BAC 
transgenes.  As the preceding background stated, the Eµ intronic enhancer 
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developmentally regulates genes at the pro-B cell stage in B-cell development.  
Therefore, the study of the Eµ enhancer in a condition specific manner is essential to 
understanding how this cis-acting element regulates genes that lead to the critical 
function of gene rearrangement, which allows the maturing B-cell to develop and 
produce a diverse antibody response.  Specifically, BAC transgenes allow the Eµ 
enhancer may to be placed in different locations to precisely determine its ability as a cis-
acting element to regulate gene rearrangement independent of distance.  While other cis-
regulatory elements have been intensely studied, such as the β-globin LCR, and new ones 
remain further examination, like the human insulin locus, the tissue-specific effects of the 
Eµ enhancer are known, including its key position adjacent to the JH recombination 
center.  Consequently, modified BAC transgenes that include the DH and JH domains, and 
the Eµ enhancer, will allow the testing of the hypothesis that the Eµ enhancer is able to 
induce gene rearrangements independent of distance and location to the JH recombination 
center.  In this thesis project, two BAC transgenes were specifically constructed to 
evaluate the cis-regulatory characteristics of the Eµ enhancer’s location and distance.  In 
one construct, the Eµ enhancer is relocated into the center of the DH domain that has a 
heterochromatin spread of ~50 kb.  In this setting, it is of particular interest to test 
whether the enhancer is able to affect chromatin, transcription, and recombination in the 
same way as the endogenous site.  In addition, when moving the Eµ enhancer into this 
heterochromatic area, the classical definition of enhancers suggests RAG binding to the 
recombination center should remain the same.  When the Eµ enhancer is moved, if the 
pattern of RAG binding also changes, then the Eµ enhancer has a direct role in 
controlling the recombination center in the endogenous setting.  This is a significant 
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experiment, as the ability of a cis-acting element to control RAG binding helps to explain 
RAG recruitment to the JH domain.    
As for the question of an enhancer’s distance to control gene regulation, one BAC 
construct has been designed to relocate the Eµ enhancer at a considerable distance from 
the endogenous site.  Both the above background and other experiments have 
demonstrated that tissue specific enhancers have a certain distance for cis-regulatory 
function.  Previous studies that dissected the Eµ enhancer demonstrated a certain distance 
where the enhancer directly impacts the chromatin and transcription landscape. From cell 
line experiments, Eµ impacts chromatin and transcription 54 kb upstream and only 15 kb 
downstream (Chakraborty et al, 2009).  It turns out that the Eµ enhancer is not the only 
antigen receptor enhancer that impacts gene regulation.  Another antigen receptor locus, 
the β locus of the T-cell receptor is controlled by the Eβ enhancer that is located 3’ of 
Cβ2, and likewise demonstrates a specific distance effect similar to the Eµ enhancer on 
the IgH locus (Oestreich et al., 2006).  When histone acetylation is analyzed in Eβ null 
thymocytes, there is a decrease at the Jβ and Cβ segments that are 20kb away.  Similar to 
the Eµ enhancer, Dβ1-Jβ1 rearrangement requires the cooperation of Eβ which must 
stimulate rearrangement over a distance of 15 kb.  Deletion of Eβ results in a loss of 
germline transcription that normally precedes any rearrangement, and homozygous Eβ-
deleted animals lack αβ T cells (Bories et al., 1996; Bouvier et al., 1996).  Likewise, two 
other antigen receptor enhancers, Eδ and Eα, have also been demonstrated to be long-
range developmental regulators of H3 acetylation (McMurry and Krangel, 2000).  
Collectively, all of these investigations on antigen receptor enhancers demonstrate that 
these cis-regulatory elements are able to positively control active histone marks at 
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distances related to their functional role in rearrangement.  This is a contrast to mouse β-
globin LCR studies that have yet to show a relationship between cis-acting elements and 
chromatin structure.  In this thesis project, the Eµ enhancer will be relocated a distance of 
54 kb upstream from its endogenous site to study its ability to control gene regulation.  It 
is of particular interest to study the issue of distance using a modified BAC construct, and 
this will directly test the classical definition of enhancers and their ability to activate 
transcription independent of distance.  Coupled to this, studying gene rearrangements in 
this distant-modified-BAC will lead to further understanding of how the recombination 
center operates based off the Eµ enhancer’s location from the endogenous site. 
Collectively, modified BAC constructs provide a tool to study the tissue specific 
Eµ enhancer in a developmental manner using pro-B cells where the main rearrangement 
event between the DH domain and JH occurs.  This system provides a mechanism to test 
the classical definition of the Eµ enhancer in an in vivo setting and either support it or 
modify it with respect to the chromatin environment.  It is of primary importance to 
further characterize the Eµ enhancer in a condition specific manner because of its critical 
role in regulating genes in pro-B cells.  At the center is the Eµ cis-regulatory element, 
and the prediction of this project is that moving the Eµ enhancer will result in a different 
chromatin, transcription, and gene rearrangement pattern than the endogenous locus. 
Related to the above project is the search for unique cis-acting elements both 
within and outside the IgH locus.  The preceding background reviewed all the major cis-
elements reported, including DQ52, Eµ, and the 3’RR.  Several DNase I hypersensitivity 
peaks have been identified throughout the 100 kb intergenic region between the most 3’ 
proximal VH gene segment and DFL16, and also upstream of the last 5’ distal VH gene 
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(Figure 5).  Nonetheless, besides the PAIR elements, no significant cis-acting element 
has been located in the VH domain, and the hunt for other cis-elements in the 100 kb 
intergenic region is needed to explain the precise timing and selection of VH gene 
rearrangements to DJH segments.   In addition, beyond the insulators within the IGCR, 
the identification of additional elements either upstream or downstream of the Eµ 
enhancer will help explain the existence of other cis-acting factors that may have a direct 
role in pro-B cell development in the bone marrow.  As outlined above, DNase I 
hypersensitivity provides a unique tool to hunt for cis-regulatory elements because 
nucleosome depleted DNA that has bound regulatory factors is more accessible to DNase 
I compared to nucleosome bound, inaccessible regions.  This experiment was modified 
for B-cells, and was subsequently executed in cell lines to test for Eµ’s ability to affect 
other cis-elements both within and outside the IgH locus.  The experiment was later 
successfully used in primary B cells from the spleen to analyze changes in DNase I 
digestion patterns at different time points and samples.  Several hurdles existed in the 
development of this experiment.  The first was the inability to produce consistent results 
using other lab protocols.  Protocols were later communicated to be cell-type specific.  
Coupled to this, some protocols used magnesium (Mg+2) in the digestion buffer.  
Magnesium speeds up the activity of DNase I in solution, and therefore many 
experiments were initially slightly over-digested.  To overcome this problem, Calcium 
(Ca+2) was replaced in the digestion buffer to slow down the activity of DNase I to obtain 
results where only about 1% of the genome was digested. 
To test for the role of Eµ to affect other regulatory elements either within or 
outside the IgH locus, three related, but different sets of pro-B cell lines were used.  All 
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three have RAG mutated to maintain the cells in the pro-B cell stage and prevent cell 
maturation.  In the first set of pro-B cell lines, termed “B6D345,” the IgH allele is in the 
germline configuration on the C57BL/6 background and lacks endogenous RAG-1, 
though has transgenic expression of the catalytically inactive RAG-1(D708A) (Ji et al., 
2010).  The purpose of using this cell line in DNase I studies is twofold.  First, it provides 
a wild-type control for the experiment, and second, since it’s on the C57BL\6 
background, it then aligns directly to the UCSC Genome Browser after sequencing.  The 
next pro-B cell line used is termed “Rag8-/-.”  These cells have the IgH locus in the 
germline configuration and are maintained in tissue culture conditions as pro-B cells as 
they are Rag2-/- deficient.  Also, they are different from the B6D345 cell line because 
they are on the mouse 129 strain background (Simpson et al., 1997).  In an identical 
fashion to these cells, but with one significant alteration, is the third pro-B cell line, 
termed “Rag2-/- Eµ-/-.”  This third set has the core domain of the Eµ enhancer deleted, 
along with the Rag2-/- deficiency (Perlot et al., 2005).  As a result, any changes due to 
the enhancer deletion in the Rag2-/- Eµ-/- cells are observed when comparing to the 
Rag8-/- cells.  While both of these cell lines are on the 129 mouse strain background, 
differences at the sequencing level can be mitigated with the B6D345 which aligns 
exactly with the C57BL\6 strain used to generate the alignment in the UCSC genome 
browser.  At the outset, the B6D345 was included due to the unknown nature of the 129 
mouse strain aligning with the C57BL\6 strain.  In retrospect, no significant differences 
were observed between these two strain alignments. 
In conclusion, this introductory background has effectively set up the central 
paradigm of this thesis: to study the cis-regulatory features of the Eµ enhancer as it 
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relates to gene regulation (project 1), and to determine whether the Eµ enhancer affects 
other cis-acting elements within the IgH locus or outside of it (project 2).  The first 
project will test whether an enhancer’s position is necessary for its function, and the 
second project will interrogate the entire genome for DNase Hypersensitivity peaks that 
either relate directly or indirectly to the Eµ enhancer.  These projects will provide an 
essential understanding for how the Eµ enhancer gives rise to the genomic events that 










Figure 1.  B Cell Development, Immunoglobulin Gene Rearrangement and 
Structure of the Pre-BCR.  (A) Schematic illustration of B-Cell development as it 
relates to immunoglobulin gene rearrangement.  Also shown are the CD antigens and 
other proteins that are expressed at different stages to yield a functional B-cell receptor.  
After successful heavy and light chain rearrangement in the bone marrow, immature B 
cells migrate to peripheral organs (spleen, lymph nodes) where maturation is completed. 
B-cells proliferate extensively in germinal centers where they may undergo class switch 
recombination and somatic hypermutation to yield antibodies with different effector 
functions and higher affinity.  Some activated B-cells differentiate into memory cells and 
others in to antibody-secreting plasma cells. (B) The Pre-BCR consists of a rearranged Ig 




Figure 2.  Structure of Antibody Molecule.  Antibody molecules are composed of two 
identical heavy chains (VH) and light chains (VL).  Each VH and VL has an antigen-
binding variable region that determines the specificity of the antibody and a constant 
region that communicates the effector function.  All the chains in an antibody are held 
together by disulfide bonds.  The variable region can be further divided into four 
framework regions and three complementarity determining regions.  Some heavy chain 




Figure 3.  Organization of the 3 Mb IgH Locus in Germline Configuration, Mouse 
Chromosome 12.  Schematic illustration above is based on C57BL/6 (Johnson et al., 
2006), F1 long arm of mouse chromosome 12.  The names of each of the four gene 
segment families is above each respective region.  Also included are the three major cis-
regulatory elements of the IgH locus PDQ52 , Eμ, and the 3’RR.  The most 5’ variable gene 








Figure 4.  RAG and RSS engagement.  (A) Depicted above is the recombination signal 
sequence (RSS) that has a heptamer, a spacer of 12 or 23 bp, and a nonamer.  Only a 12-
bp spacer can recombine with a 23-bp spacer gene segment.  These RSS sequences are 
adjacent to each antigen receptor gene segment.  In the initial step of gene rearrangement, 
RAG 1 and 2, bind to either the 12-bp RSS or 23-bp RSS, in the presence of HMGB1. 
(B) The rearrangement process shown above is that for the IgH locus  The D (diversity) 
and J (joining) gene segments undergo rearrangement first, followed by rearrangement of 
the V (variable) gene segment to the DJ locus.  The complete rearranged V(D)J locus is 
first transcribed into mRNA and then translated into the μ-heavy chains.  Shown at 
bottom is the hypervariable region of the antigen receptors, known as CDR3 and encoded 




Figure 5.  Overview of  cis-acting elements on the IgH locus.  This schematic 
illustration gives an overview of the cis-regulatory elements on the IgH locus that have 
been reported.  It does not include CTCF elements that have been reported throughout the 
IgH locus.  Shown are the DNase I hypersensitivity peaks that have led to cis-regulatory 
additional studies to determine the function of these sites.  While some have had a 
significant role in cis-regulation of the IgH locus (Eμ, 3’RR), others have no functional 




Figure 6.  RAG Association and Histone Modifications on Germline IgH Locus. 
This schematic is updated from Sen and Oltz 2006 to represent the pattern of histone 
modifications and RAG association as currently known on mouse chromosome 12, 
germline configuration.  Active histone marks (green) closely follow RAG binding (red), 
and suppressive histone marks (brown) dominate the DSP region.  RSS segments are 



























Gene regulation in mammals is central to understanding cellular development.  
Enhancers are critical cis-regulatory elements that recruit transcription factors to modify 
chromatin structure for coordinated gene expression.  Initially discovered in the genome 
of simian virus 40 (SV40), enhancers have been observed in transient expression assays 
to activate transcription independent of their distance relative to their gene promoters  
(Banerji et al. 1981; Ong et al., 2011).  The Eµ intronic enhancer was the first 
transcriptional tissue-specific enhancer discovered, as it was able to drive the expression 
of immunoglobulin or other transgenes in a position independent manner in lymphoid 
cells alone (Alt et al., 1982; Banerji et al. 1983; Gilles et al., 1983; Neuberger 1983).  As 
a cis-regulatory element, the Eµ enhancer has been demonstrated to have a critical role in 
both the expression of genes and recombination events at the pro-B cell stage of mouse 
B-cell development. 
 Located on mouse chromosome 12, the Eµ intronic enhancer is part of the 3 Mb 
immunoglobulin heavy (IgH) chain gene locus that encodes antigen receptors for 
lymphocytes (Chowdhury and Sen, 2004).  The IgH locus contains variable (VH), 
diversity (DH), joining (JH) gene segments and constant (C) region exons.  These V(D)J 
gene segments participate in two recombination events to produce a complete rearranged 
IgH allele in pre-B cells.  In a precise and stepwise order, gene rearrangement between 
the D to JH loci is always initiated in pro-B cells prior to the V to DJH rearrangement.  
Both “recombination centers” and the “accessibility hypothesis” explain this ordered 
sequence of recombination events (Ji et al., 2010; Yancopoulos and Alt, 1985).   
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 First, in order for gene rearrangements to proceed on the IgH locus, RAG 
recombinase must be recruited to the antigen receptor genes to introduce double strand 
breaks at accessible recombination signal sequences (RSSs).  The recombination center is 
the formation of local RAG-binding regions that serve as the selected sites where antigen 
receptor gene segments are captured for recombination.  The highest density of RAG 
binding in pro-B cells has been identified in the JH locus, which partly explains why the 
initial recombination step is between the DH and JH gene segments (Ji et al., 2010). 
 Second, the accessibility hypothesis originally suggested that it was the presence 
of accessibility control elements (ACE) at the individual antigen receptor loci that lead to 
ordered genetic rearrangements (Yancopoulos and Alt, 1985).  Using a combination of 
transgenic models and in vitro systems, both transcriptional enhancers and promoters 
were found to be cis-acting ACEs that regulate the cell type-specific chromatin structure 
to determine the targeting of RAG recombinase.  It is then precisely the coordinated 
accessibility of both an antigen receptor gene locus and its ACEs to the RAG 
recombinase that determines the specific selection of DH and JH antigen receptor genes to 
initiate recombination in pro-B cells. Such cis-regulatory ACEs are then central to the 
core features of both the accessibility hypothesis and the local RAG-bound 
recombination centers. 
 One significant cis-acting ACE that has been identified to have a significant role 
related to DH to JH recombination in pro-B cells is the 700 bp Eμ enhancer.  Situated 
between the JH-Cμ intron, deletion of the Eμ enhancer led to a significant reduction in DH 
to JH rearrangements and a major defect in the subsequent VH to DJH rearrangement 
(Afshar et al., 2006; Perlot et al., 2005).  The Eµ enhancer has a 220 bp core region (cEμ) 
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and is surrounded on each side by matrix attachment regions (MARs) (Gillies et al., 
1983; Jenuwein et al., 1997).  Deletion of cEμ resulted in reduction in transcription and 
transcription-associated histone modifications, as well as significant impairment of DH to 
JH gene rearrangement (Chakraborty et al., 2009).  These investigations into both Eμ and 
cEμ have demonstrated the enhancer’s pivotal role as a cis-regulatory element that 
controls epigenetic modifications, transcriptional regulation, and DH to JH recombination  
 Given the historical view of enhancers as able to activate transcription 
independent of their distance relative to the promoters of gene, this project directly tested 
whether or not the location of the Eµ intronic enhancer in the IgH locus is required for its 
gene regulatory function and if the enhancer’s function as it relates to gene rearrangement 
changes based on the location.  No studies have examined within an in vivo setting 
whether the distance of an enhancer is critical for the appropriate gene expression and 
resulting phenotype.  For this investigation, we generated bacterial artificial chromosome 
(BAC) transgenic mice that contain the Eµ intronic enhancer in different locations and 
assayed chromatin, transcription, and recombination.  Using this system, we were able to 
test the hypothesis that enhancers are cis-acting elements that activate transcription 
regardless of location to their gene promoters.  Our results demonstrate that regions of 
heterochromatin can be changed to euchromatin from the location of the Eμ intronic 
enhancer, and that when the location of the Eμ intronic enhancer is changed, unique 
transcripts and rearrangements are induced compared to the endogenous state.  Therefore, 
the precise location of Eμ is essential to generate normal chromatin structure, optimal 
transcription and DH to JH rearrangements.  From this study of the Eμ enhancer in 
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different locations on modified BACs, a new view of enhancers has emerged where their 
























 BAC transgenic mice were developed as described in the Materials and Methods 
section.  A schematic representation of the 11 kb BAC construct and 181 kb insert is 
given in Figure 7, and an overview of the modified BACs with the relocated Eµ enhancer 
is in Figure 8.  In brief, C57BL/6 mice carrying the modified BAC constructs were 
generated by recombineering experiments carried out by Dr. Changying Guo and the 
injections of the modified BACs were performed at the University of Connecticut.  
Transgene positive C57BL/6 founder mice were initially bred to JHT mice that have a 4 
kb deletion between the Xho I and EcoR I sites that are directly upstream of DQ52 and 
downstream of Eμ, respectively (Gu et al., 1993).   The purpose of this breeding was to 
ensure that all measurements reflected the transgene and not endogenous IgH alleles.  
After this initial breeding, transgene positive mice were subsequently bred to JHT.  
Founder mice of different transgenic strains were separated by mouse tags in the BRC 
Mouse Core Facility.  Each transgenic strain had two sets of founders except EU+.  To 
test for the presence of the transgene in the mice prior to experiment, genotyping was 
performed using several sets of primers that anneal to BAC specific regions that are 
outlined in the Material and Methods section and shown in Figure 9.  In all experiments 6 
mice, ages 8-10 weeks, were sacrificed and bone marrows were flushed for each 
individual transgenic strain.  Cells were collected and CD19+ B cells were isolated by 
positive selection using Stem Cell’s Robosep Isolation System (Stem Cell #18754).  
Approximately 5 million cells were present after isolation, and from this pool, three 
divisions were made for the cells: (a) 5 x 105 cells were used for subsequent RNA 
isolation, (b) 5 x 105 were used for DNA isolation for downstream rearrangement assays 
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and (c) the remaining cells were plated for expansion onto an OP-9 stromal layer as 
described in the Material and Methods.  Both FACs analysis and Southern Blots were 
performed to confirm pro-B cell identity and transgene presence on JHT background in 
experimental mice (Figures 10 and 11).  All probes are listed in the Material and Methods 
section.  Southern blots also measured transgene copy number, which was quantified for 
both founder sets of mice using Qiagen’s Biomarker Copy Number PCR Assays (Catalog 


















Results and Discussion 
Modified BAC Transgenic Overview 
 In order to test the hypothesis that enhancers are cis-regulatory sequences that 
activate transcription regardless of location to their gene promoter, six different transgene 
constructs from the RP23-458I14 BAC were modified based on a 181 kb sequence from 
mouse chromosome 12 (Figure 7a).  Each modified BAC represented the 181 kb region 
between positions 114,567,000 – 114,748,000 on the C57BL/6 mouse chromosome 12 
(Figure 7b).  This region starts 80 kb upstream of DFL16.1 (chromosome 12: 
114,668,722) and ends approximately 5 kb downstream of Cγ1 (Figures 3, 7B).  
Importantly, there are no V gene segments in the BAC (Figure 7c).  This allowed the 
study to focus solely on the effects related to the DH and JH gene segments with respect to 
the relocation of the Eμ enhancer in the modified BACs. 
 The constructs were specifically designed to test the central hypothesis 
concerning whether the Eμ intronic enhancer has the same gene regulatory functions on 
the IgH locus independent of distance from its endogenous site.  A schematic 
representation of each BAC construct is depicted in Figure 8.  As illustrated in Figure 12, 
the BACs were given the following labels: EU+, EU-, DSP, DPEU, VD, and VDEU.  
The first pair, EU+ and EU-, are constructs identical to the aforementioned defined area 
of C57BL/6 mouse chromosome 12, with the exception that the EU- construct has the 
endogenous 700 bp Eμ deleted that is between the Xba I and EcoR I sites  (chr12: 
114,665,495 – 114,666,183).  These two BAC constructs allow comparison to prior 
chromatin, transcription, and recombination experiments performed in pro-B cells in 
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order to address whether the transgenes were able to recapitulate the gene regulatory 
landscape in pro-B cells (Chakraborty et al., 2009).  
 The next pair of BACs, DSP and DPEU (Figure 8) represented the first modified 
BACs where the Eμ enhancer was relocated.  These BACs were identical in that each 
contains the Eμ enhancer in the middle of the characterized heterochromatic DH-region 
on mouse chromosome 12 at position 114,697,256 - 114,697,956, which is 31 kb 
upstream from the endogenous site.  This region is flanked by DSP2.x upstream and 
DSP2.3/4 downstream.  However, there was one critical difference between the DSP and 
DPEU transgenes.  In the case of DSP, there is no Eμ enhancer in the endogenous 
location, whereas the DPEU construct contains two Eμ enhancers, one in the endogenous 
location and one within the DH - gene segments.  This allowed any effect observed from 
the relocated Eμ enhancer to be associated with the Eμ enhancer and no other gene 
regulatory element.   
 To test whether a distant Eμ enhancer was able to regulate gene expression in the 
same way as the endogenous Eμ enhancer, we designed the VD and VDEU constructs.  
These constructs had the Eμ enhancer located 5 kb upstream of DFL16.1 (chromosome 
12:114,720,388) and 59 kb from the endogenous location.  While both the VD and 
VDEU constructs contained the relocated Eμ, only the VDEU construct had both the 
relocated Eμ enhancer and the Eμ enhancer in the endogenous location.  This allowed any 
effect detected from the distant relocated Eμ enhancer to be associated with the Eμ 
enhancer and no other cis-acting element.  In summary, the DSP transgene allowed the 
study of both distance and whether regions of heterochromatin are able to be changed by 
the presence of an enhancer.  The VD construct allowed the question of distance to be 
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answered, as the Eμ enhancer is 59 kb from the endogenous site.  Together, these 
constructs and the outlined control BACs, EU+ and EU-, were able to fully examine 
whether enhancers can regulate gene expression independent of location.  Each of these 
modified BAC inserts were placed into the pBACe3.6 vector and delivered into C57BL/6 
mice by pronuclear injection. 
 
Epigenetic and Transcription Profiles of EU+ and EU- Transgenes 
 In order to compare the modified transgenic mice, we set out to determine 
whether the control set of transgenes, EU+ and EU-, recapitulated the transcriptional and 
epigenetic profiles of chromosomal IgH alleles (Chakraborty et al., 2009).  For epigenetic 
analysis, we carried out chromatin immunoprecipitation studies from expanded OP-9 pro-
B cells using antibodies directed against histone modifications associated with gene 
activation (H3K9ac and H3K4me3) and gene inactivation (H3K9me2). With respect to 
active chromatin modifications in EU+, both H3K9ac and H3K4me3 had a 
distinguishable pattern where the greatest presence of these active marks was at JH2 
(Figure 13A, B, blue bars).  In EU+, there was a stepwise pattern that started with low 
active marks at Cγ3 and peaks at JH2.  There was then a subsequent decrease in active 
marks at DQ52, and this was reduced further as minimal active histone marks were 
detected upstream of DQ52 in the EU+ mice.  This epigenetic profile was very similar to 
that of endogenous IgH alleles (Chakraborty et al., 2009). 
 In the EU- transgene, both H3K9Ac and H3K4me3 levels were reduced at Cμ 
compared to EU+ alleles (Figure 13A, B, red bars).  Outside of these two sites, active 
marks were not detected in the EU- transgene.  The pattern of H3K9me2, a marker of 
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inactive chromatin, was similar in both EU+ and EU- transgenes, but the EU- transgene 
had elevated H3K9me2 at both JH2 and DQ52 (Figure 13c, blue and red bars, 
respectively).  From Cμ to DFL16.1, there was a successive increase in H3K9me2 with 
significant elevation in the DH region.  Just as the DH region is dominated by 
heterochromatin marks in pro-B cells, the EU+ and EU- transgenes shared the same 
heterochromatin pattern.  The DSP gene segments have high levels of heterochromatin 
regardless of whether Eμ is present or absent.  Putting both the active and inactive 
chromatin patterns together, the EU+ and EU- BAC transgenes effectively represent the 
gene regulatory pattern of Eμ with respect to active and inactive chromatin modifications 
as found in the endogenous IgH locus of mouse pro-B cell lines. (Chakraborty et al., 
2009) (Figure 6).   
Since the Eμ enhancer in the EU+ control transgene had a similar epigenetic 
profile to that in Eμ sufficient mouse pro-B cell lines, we determined the Eμ enhancer in 
the EU+ control transgenic mice was also able to induce transcription of genes due to the 
permissible chromatin structure at different loci.  In the EU+ control transgene, Eμ 
dependent transcription of genes was observed only at DQ52 when compared to the EU- 
transgene (Figure 14A, blue and red bars, respectively).  Upstream of DQ52, there is 
minimal transcription throughout the DH domain in both the EU+ and EU- transgenes 
which reflects the heterochromatin structure of the DSP region.  Therefore, both the 
chromatin and transcription profiles in the EU+ and EU- BAC transgenes effectively 
reflected the gene expression pattern of Eμ as found in the endogenous locus of mouse 
pro-B cells (Chakraborty et al., 2009) (Figure 6).  We were then able to test the gene 
88
regulatory effects of the relocated Eμ enhancer in the four other constructs: DSP, DPEU, 
VD, and VDEU. 
 
Epigenetic and Transcription Profiles of Relocated Eμ enhancer in DSP Region 
 After observing close similarity between the regulation patterns of the control 
BAC transgenes and those of the endogenous IgH alleles, we investigated the effects of 
relocating the Eμ enhancer into the heterochromatic DSP region.  We found that both 
activation marks (H3K9ac, H3K4me3) were present in the DSP region when the Eμ 
enhancer was relocated into the DSP gene segments in the DSP transgenic mouse (Figure 
13A and B, green bars).  The pattern between DSP and EU- was similar at Cγ3, Cμ, and 
Eμ+1, which is attributed to both transgenes having a deleted Eμ from the endogenous 
location.  At JH2, a significant increase in active histone marks was observed in DSP 
compared to EU- transgenic alleles, however, levels did not reach to those present in EU+ 
alleles.  This active region peaked at DQ52 and then decreased to DFL16.1, though it was 
still detectable and was nearly ~2.5 times higher than EU-.  Conversely, inactive 
H3K9me2 marks for DSP were significantly reduced throughout the DH region from the 
relocated Eμ (Figure 13C).  Therefore, with a relocated Eμ enhancer in the middle of the 
DSP gene locus, chromatin marks shift from a region dominated with heterochromatin in 
EU+ and EU- settings, to active marks that are associated with gene activation in the DSP 
transgenic mouse. 
The pattern for double-enhancer alleles in DPEU transgenic mice was similar to 
DSP in the DH region but at higher amounts for H3K9ac and H3K4me3 (Figure 13D and 
13E, purple bars).  In addition, for the DPEU transgene, the Eμ enhancer located in the 
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endogenous location followed the same pattern for active and inactive marks compared to 
the EU+ transgene between Cγ3 and JH2.  Consequently, the Eμ enhancer in the 
endogenous setting for the DPEU transgene was able to maintain active chromatin marks 
within a set distance that was distinguished from the DSP transgene.   This was 
confirmed in DSP, as the relocated Eμ enhancer was able to induce chromatin changes 
within the DH gene segment only, and not downstream of JH2.  We conclude that the Eμ 
enhancer is able to ‘open’ heterochromatin and induce active chromatin marks.  
The presence of new euchromatin in the DSP transgene was reflected in unique 
transcripts that were induced at DSP2.3 and remained throughout the DH domain (Figure 
14A, green bars).  A similar pattern, but elevated transcript levels were observed for 
DPEU (Figure 14A, purple bars).  Therefore, without the Eμ enhancer, the chromatin in 
the DH region is closed and the genes are transcriptionally silent.  When the Eμ enhancer 
is relocated to the middle of the DH region, the chromatin configuration changes and 
unique transcripts are induced in nearby genes.  
  
Epigenetic and Transcription Profiles of Relocated Eμ enhancer 5’ DFL16.1 
In the last level of comparison, when the Eμ enhancer was located 59 kb from the 
endogenous location in the VD transgenic model, only local chromatin remodeling for 
active histone marks was observed at DFL16.1 (Figure 13G, H, black bars).  In every 
other region analyzed, the VD transgene was similar to the EU- transgene for both active 
and inactive histone modifications (Figures 13G - I).  While VDEU has active histone 
marks between Cμ and JH2, these modifications were attributed to the Eμ enhancer in the 
endogenous location and not the distal Eμ enhancer (Figure 13G, H, orange bars).  
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Similar to DPEU, the VDEU transgene was also able to restore and maintain the 
chromatin structure in the endogenous Eμ, peaking at JH2.  Therefore, in the distant Eμ 
enhancer VD transgene, the effects of the relocated Eμ enhancer were isolated to 
DFL16.1 and the Eμ enhancer was unable to affect chromatin structure from a distant 
location. 
Similar to the chromatin pattern for the VD transgene, only minimal transcripts 
were observed throughout the DH domain, with a slight increase in transcript level at 
DFL16.1 (Figure 14B, black bars).  The VDEU transgene was similar, but had significant 
transcription at DQ52 and this was attributed to the Eμ enhancer located at the 
endogenous location (Figure 14B, orange bars).  Therefore, the main theme that emerged 
was that Eμ enhancer was not able to generate the same chromatin or transcription 
patterns independent of location, but was able to affect unique chromatin and 
transcription patterns that were dependent upon the enhancer’s location. 
 
 DH to JH Rearrangement in Transgenic Mice 
Next, we set out to determine if relocating the Eμ enhancer had any functional 
effects with respect to gene recombination.  In order for gene rearrangement to take place 
between the DH and JH gene segments, an RSS must be accessible at each unrearranged 
gene so that RAG recombinase may be recruited to the loci targeted for rearrangement.  
Each RSS sequence consists of a conserved heptamer and nonamer.  These sequences are 
separated by either a 12 or 23 bp spacer sequence that is less conserved and these spacers 
define the two types of RSSs, 12-RSS and 23-RSS.  Known as the 12/23 rule, efficient 
recombination only takes place between a 12-RSS and a 23-RSS. 
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In order to study gene rearrangement in the transgenic mice, genomic DNA was 
amplified from isolated CD19+ pro-B cells using 5’ primers that hybridize to either 
DFL16.1 or multiple DSP gene segments, and a common 3’ primer that is located 
downstream of JH3.  We used the non-rearranged β2-microglobulin gene (β2M) to 
normalize DNA used for the recombination assays.  As shown in Figure 15, comparable 
levels of gene recombination were detected in the EU+ strain when compared to 
C57BL/6 bone marrow cells isolated by CD19+ selection.  As expected, minimal gene 
rearrangements were detected in the EU- transgenic mice.  Therefore, the EU+ transgenic 
allele was able to effectively induce gene rearrangements.  We consistently detected 
rearrangements using both the DFL16.1 or DSP primers in DSP mice that were either 
comparable to EU+ or slightly less.  When the relative band signal intensity was 
quantified using the Gene Tools Syngene program for the DSP to JH gene 
rearrangements, the DSP transgene had a greater intensity than EU+ for DSP-JH2 and 
DSP-JH3 rearranged alleles, but less than DPEU for each rearrangement (Figure 15B).  
For the DPEU mouse strain, gene rearrangements were of greater intensity than DSP due 
to having both the relocated Eμ and the endogenous Eμ.  In the VD strain, few 
rearrangements were detected using either the DSP or DFL16.1 primer, which were 
comparable to the EU- strain (Figure 15).  For the VDEU strain, all gene rearrangements 
were comparable to EU+, and thus the Eμ in the endogenous location and not the distal 
Eμ enhancer was directing gene recombination events on this allele (Figure 15).  
Therefore, while the Eμ enhancer was able to direct gene rearrangements, it was only the 
single Eμ enhancer in the DSP strain that was able to induce unique recombination events 
at a level comparable to the endogenous setting using either DFL16.1 or DSP primers.  
92
This was reflected in both the chromatin and transcription data, where the typically 
heterochromatic DSP locus was opened in the DSP mouse and had both active histone 
marks and unique transcripts.  These characteristics then allowed the Eμ enhancer in the 
middle of the DSP region to activate gene recombination events with any of the 
associated JH segments.  As the chromatin and transcription data indicated minimal locus 
opening from the distal Eμ enhancer in the VD mouse, it was also observed to have 
minimal gene rearrangements and those detectable rearrangements were from the 
DFL16.1 primer that is located 5 kb near the relocated Eμ enhancer. This data indicates 
that Eμ can activate DH recombination only from select locations within the DH - Cµ 
region. 
Next, we set out to determine whether the relocated Eμ enhancer affected all DSP 
gene segments equivalently.  Since the chromatin structure was opened by the presence 
of the Eμ enhancer in the middle of the DH gene segments, it was critical whether all of 
the RSS sequences from the D-gene segments were used for gene rearrangement as a 
result of the chromatin opening, or whether the Eμ enhancer was only able to affect some 
DH gene segments over others.  In order to determine the D-gene usage in these 
recombination events in the EU+, DSP, and DPEU transgenic mice,  90 PCR amplicons 
from the DJH rearrangement gels were cloned and sequenced (Figure 16).  Due to the 
heterochromatin structure of the DH locus in the EU+ transgene, it was predicted that the 
Eμ enhancer in the EU+ transgene would initiate rearrangements with one of the outer 
and accessible genes in higher amounts than the interior, inaccessible genes.   In the EU+ 
strain, such rearrangements were observed to be mainly at the DSP2.2 gene segment, but 
then dispersed throughout all the other DSP gene segments at much lower levels (Figure 
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16).  In contrast to the pattern of rearrangements in EU+, we found that for the relocated 
Eμ enhancer in the DSP and DPEU strains, the majority of gene rearrangements occur at 
DSP2.3/4, which is the first downstream DSP gene of the relocated Eμ enhancer.  This 
was evident for both the DSP and DPEU transgenes.  Although there are active histone 
proteins throughout the DH gene locus, the DSP2.3/4 was used in much greater 
proportion than any other gene segment.  We attribute the selection of this gene segment 
to the Eμ enhancer affecting the closest gene promoter to induce gene rearrangements, 
with relatively little effect on other DSP gene segment. 
 
 RAG Recombinase Accessibility in Transgenic Mice 
 Next, we set out to determine the mechanism of this functional recombination 
data.  It has been previously demonstrated that binding of RAG protein to accessible 
DNA takes place in a focal manner, and is limited to sites that have elevated levels of 
H3K4me3 and RSS sequences.  The stationing of these local RAG-bound areas are 
known as “recombination centers.”  Such regions of distinction are developmental and 
lineage-stage specific and their purpose is to coordinate V(D)J recombination so as to 
provide the specific sites where the antigen receptor gene segments are captured for 
recombination (Ji et al., 2010). 
 To probe for the presence of recombination centers in the different transgenes, 
and to see whether or not the RAG protein was driving these recombination events, we 
performed RAG ChIP experiments to detect the presence of RAG across different DH and 
JH gene segments.  We observed that the presence of RAG1 and RAG2 in the JH gene 
segments was highest in each strain that had both Eμ enhancers (EU+, DPEU, VDEU), 
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and only in the DSP strain was this focal establishment of RAG-1/2 in the JH region 
maintained (Figure 17).  Minimal levels of RAG1 and RAG2 protein were detected in 
both the EU- and VD strains. As one moves upstream from the JH genes and into the DH 
region, the level of RAG binding at DQ52 drops off, and decreases further at DSP2.2 in 
EU+, DSP, DPEU, and VDEU.  It then increases at DFL16.1 in each of these strains to 
levels that are above DQ52 yet below both JH2 and JH4.  As a result, recombinase 
accessibility to the recombination center remains highest in the JH gene segments for 
those strains that have the Eμ in the endogenous location (EU+, DPEU, and VDEU), and 
only the single relocated Eμ enhancer in the DSP mouse strain demonstrates a similar 
pattern (Figure 17).  While the Eμ enhancer in the DSP mouse is able to induce unique 
rearrangements, it is because of the focal binding of RAG-1/2 to the JH gene segments 
and the presence of the recombination center that the Eμ enhancer in the DH locus is able 
to induce gene rearrangement events.  When this focal binding of RAG is removed, such 
as the VD mouse, minimal rearrangements are able to take place as no recombination 
center is present. 
In conclusion, this project demonstrated that the Eμ enhancer is able to induce 
unique transcripts and recombination events in the DSP mouse, as it is able to open the 
local heterochromatin structure.  This configuration allows the focal establishment of 
RAG-1/2 binding in the JH gene segments and the existence of the recombination center 
to remain, so that unique recombination events occur as a result of the relocated Eμ 
enhancer.  However, these observations are limited to the DSP mouse where the Eμ 
enhancer is 31 kb upstream from the endogenous site and not the VD mouse where the 
Eμ enhancer is located 59 kb upstream from the endogenous site.  In the VD transgenic 
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lines, transcription and active chromatin modifications were limited to DFL16.1, though 
at lower levels.  Therefore, the VD mouse essentially represented the EU- mouse with the 
only difference of the enhancer’s location 5 kb upstream of DFL16.1.  We conclude that 
the recombination between DH and JH gene segments is dependent on the location of the 
Eμ enhancer.  In light of this, the in-vitro definition that enhancers are cis-regulatory 
sequences that activate transcription regardless of location and orientation to their gene 
promoters must be reconsidered at least for the Eμ enhancer.  This hypothesis is not true, 
as the Eμ enhancer’s precise location is essential to generate normal chromatin structure, 
optimal transcription, DH to JH rearrangements, and pro-B cell development.  In this 
study, chromatin structure dictated whether or not transcription and recombination can 
occur, and this was dependent on the extent to which the Eμ enhancer was able to open 
the chromatin structure.  In the DSP mouse strain, the Eμ enhancer changed the local 
chromatin configuration to histone marks associated with gene activation, while the 
extent was very minimal in the VD mouse strain.  Thus, not only was the chromatin 
structure changed in the DSP mouse from the Eμ enhancer, but the open chromatin 
structure configuration allowed the RAG-1/2 recombination center to be established, 
leading to gene recombination events that were unique to the relocated Eμ enhancer.  We 
conclude the precise location of the Eμ enhancer is required for normal chromatin 










Figure 7.  Schematic representation of BAC construct and insert. (A) Each 
modified BAC originated from RP23-458I14 and contains the region between 
114,748,000 – 114,567,000 on mouse chromosome 12 as represented by the mm9 
sequence assembly, http://genome.ucsc.edu. (B) The BAC vector sequence is 11 
kb and contains a PI-SceI linearization site, along with the Sacb selection gene. 
(C) The BAC constructs contained no VH -gene segments and was confirmed to 
be 181 kb by PCR.  Shown on the top gel are different sets of primers that 
were used to map the BAC.  Included is the SacB primer, which is specific for 
the backbone of the BAC vector.  The bottom gel is DNA from the B6D345 
pro-B cell line that does not contain the BAC, and therefore, this cell line has 







Figure 8.  Modified BAC construct overview.  The endogenous IgH locus of C57BL/6 
mice is depicted at the top of the diagram.  Underneath are the six modified BAC 
constructs that reflect either the Eμ enhancer in the endogenous location (EU+), deleted 
location (EU-),  relocated positions (DSP, VD), or in both the endogenous and relocated 
positions (DPEU, VDEU).  These relocated positions were selected based on distance and 
chromatin structure.  The Eμ enhancer in the VD mouse is located 57 kb away from the 
endogenous site, while the Eμ enhancer in the DSP mouse is located 31 kb and in area of 
characterized in the endogenous IgH locus as one of heterochromatin.  All constructs 















Figure 9.  Genotyping Overview to Test Presence of Transgene in BAC Constructs.  
The overall genotyping strategy is given in the illustration and 1% agarose gels above.  
The BAC constructs are derived and modified from a 181 kb sequence on mouse 
chromosome 12 (chr12:114,567,000 – 114,748,000) (Figure 11).  In (A), the basic PCR 
strategy is illustrated as it relates to the Eμ enhancer on mouse chromosome 12.  The 
“outside” genotyping primers, “Eμ 5F” and “Eμ 3,’” yields a 1.1 kb PCR band (chr12: 
114,665,284 - 114,666,383)   when the Eμ enhancer is in its normal location (EU+, 
DPEU, VDEU).  The “inside” genotyping primers, “Eμ 5F” and “Eμ 2R,’” detect 
whether Eμ is present or absent (EU-, DSP, VD), since the Eμ 2R is a reverse primer that 
is upstream of the Hinf I enzyme that defines the 3’ end of the Eμ core region.  If the Eμ 
enhancer is present as tested with the “inside” primer set, then a 650 bp product results 
(EU+, DPEU, VDEU) (chr12: 114,665,678 – 114,666,329).  Both sets of primers are 
depicted in (B), with the “outside” set represented on the left gel, and the “inside” set 
represented on the right gel.”  To detect the relocated Eμ enhancer in the DSP and DPEU 
transgene, a forward primer (chr12: 114,697,256-114,697,275) that is about 2 kb from 
DSP2.X (chr.12:114,699,580 – 114,699,720), and a reverse primer inside the Eμ 
enhancer yields a 800 bp product (C).  This primer pair is referred to as “DSP2.x_up.”  
To test for the presence of the Eμ enhancer in the VD and VDEU transgenes, a forward 
primer directly upstream of the relocated Eμ enhancer (chr12: 114,725,356 - 
114,725,375), and a reverse primer inside the Eμ enhancer yield a 750 bp product (D).  
This primer pair is referred to as “VD_up.”  To determine the presence of the transgene 
independent of the Eμ enhancer, a specific primer set that corresponds to the SacB gene, 
which is part of the vector, yields a 1.2 kb product (E).  For reference, a 1% agarose gel 
105
of the cell lines is shown in (F), where the Eμ enhancer is present in Rag8-/- and B6D345 
to yield a 1045 bp product, but the 220 bp Eμ-core that is located between the two Hinf I 




Figure 10.  FACs analysis to confirm JHT background.  Measurement of B220+ and 
IgM+ bone marrow cells.  Single-cell suspensions of bone marrow cells from femora and 
tibiae of transgenic mice were resuspended in ACK lysis buffer (155 mM NH4Cl, 10 mM 
KHCO3, 100 μM EDTA) for 1 min at room temperature to lyse red blood cells before 
staining in FACS buffer (PBS, 0.5% BSA, 0.01% NaN3, pH 7.2-7.4) containing the 
appropriate, pre-titered B-cell marker antibodies (B220 FITC, BD catalog #, 561876; 










Figure 11.  Southern Blot to Confirm Presence of Transgene and Relative Copy 
Number.  Southern blots were performed to confirm the presence of the transgene on the 
JHT background, and relative copy number.  The southern blot in (A) shows the 
transgene in the bottom band and JHT background in the top band.  Probe used to detect 
transgene on JHT background is in red color in the schematic and is described in the 
Materials and Methods and is from chr12: 114,669,611 – 114,670,131.  Kidney DNA 
samples were digested with BamH I, which is shown in orange bars in the schematic. 
This enzyme has four cut sites on wild-type alleles: one 2 kb upstream of DQ52 and 
outside of the JHT deletion, one between DQ52 and JH1, one between JH1 and JH2, and 
one 5 kb downstream of the Eμ enhancer.  Transgene samples on a JHT background yield 
two bands, one at 7,062 bp that corresponds to the JHT background, and one at 2,318 that 
marks the BAC transgene as it reflects mouse chromosome 12: 114,668,479 – 
114,670,802.  The southern blot in (B) is for a probe that detects only the SacB sequence 
when the transgene is cut with Spe I enzyme to yield a 1,562 bp band that is on the 
backbone of the BAC, which illustrated beneath the gel.  In both gels, the relative copy 




Figure 12.   Copy Number in Transgenic Mice.  Mouse-specific qPCR copy number 
assays (qBiomarker Copy Number PCR Assays) were purchased from Qiagen.  A mouse 
multicopy reference assay (Qiagen, Catalog #. VPM000-0000000A) was used to 
normalize input DNA. Primers were specific for mouse chromosome 12:114,630,601 – 
114,630,800 (Qiagen, Catalog #. VPM112-0573154A).  Copy number was similar within 





























Figure 13.  Eμ Dependent Histone Modifications in BAC Transgenes.  CD19+ bone 
marrow pro-B cells of BAC transgenic mice were grown on OP-9 cultures for 9 - 11 days 
and used in chromatin immunoprecipitation (ChIP) assays using anti-H3K9ac (A, D, G), 
anti-H3K4me3 (B, E, H), or anti-H3K9me2 antibodies (C, F, I).  After formaldehyde 
crosslinking the cells, the crosslinked protein-DNA complex was extracted by lysis to 
produce nuclear material that was subsequently sheared by sonication to yield only 
protein binding sequences.  Referenced antibodies were then used to selectively enrich 
for the protein-DNA complex of interest.  Crosslinks were then reversed and the DNA 
was purified and quantified fluorometrically for qPCR.  A total of 200 pg was used in 
each qPCR reaction.  Experiments pooled six mice of each genotype of separate 
founders.  Similar results were obtained for each founder set (Materials and Methods).  
Data from Founder Set 1 is displayed on top, and data from Founder Set 2 is displayed on 
bottom.  Positions of amplicons are displayed by the red bars in the IgH schematic at the 
top of each figure.  Results shown are from two independent cell preparations and 
immunoprecipitates analyzed in duplicates.  Error bars represent standard deviation 








Figure 14.  Eμ Dependent Histone Transcription in BAC Transgenes.  Total RNA 
was obtained from primary bone-marrow pro-B cells of each transgenic mouse strain and 
converted into complementary DNA using random hexamers and reverse transcription 
(Invitrogen, catalog # 10928-034).  Samples were quantitated and assayed by qPCR for 
amplicons that are shown in the schematic at the top of this figure.  To compare between 
transgenes, the data with each primer pair was normalized to γ-actin expression level.  
Data shown is the mean of two independent RNA isolations from each transgenic strain 
in duplicates with each primer set for each founder.  Figure (A) shows transcripts for EU
+, EU-, DSP, and DPEU.  Figure (B) shows transcripts for VD and VDEU.  Founder 1 is 
at the top, and Founder 2 is at the bottom of each figure.  Error bars indicate the standard 







Figure 15.  Eμ Induced DH to JH Gene Recombination in Transgenic Mice.  (A) PCR 
analysis of DH to JH gene rearrangements in primary CD19+ pro-B cells from the bone 
marrow of each transgenic mouse.  β2-microglobulin used as a loading control to ensure 
equal loading of DNA from all samples.  Genomic DNA was prepared from 6 mice of 
each strain and used to analyze DSP2 and DFL16.1 rearrangements as described in the 
Material and Methods section.  Data from founder set 1 is on top and founder set 2 is on 
the bottom.  Location of the DH specific forward primers and the common JH reverse 
primer are shown in red bars under the schematic at the top of the figure.  Following 
PCR, the products were fractionated through a 1% agarose gel for 45 minutes, 120V and 
analyzed on Syngene’s G:BOX F3 Gel Imager.  The relative band intensity was measured 
for the DSP to JH gene rearrangements for founder set 1 of each transgenic strain in (B), 
quantified by using the Gene Tools Syngene program.  Data shown is representative of 




















Figure 16.  Eμ Induced D-gene Rearrangements in Transgenes.  DSP-JH 
rearrangement PCR products were fractionated through a 1% agarose gel, extracted, and 
bands for JH1, JH2, and JH3 were cloned into a TA Cloning Vector (Invitrogen, catalog 
# K2020-20) for EU+, DSP, and DPEU transgenic strains.  Clones were then sequenced 
and the number of DH¬ genes utilized for each transgenic strain is given in (A).  A table 
of the sequences is given in (B - F) with the germline sequence at top and each DH to JH 
rearrangement underneath.  A list for DSP2.9 is in (B), DSP2.2 in (C), DSP2.x (D), 








Figure 17.  Binding of RAG-1 and RAG-2 in Transgenic Mice.  Binding of RAG-1 
(A) or RAG-2 (B) was assessed by ChIP using primary CD19+ pro-B cells from the bone 
marrow of representative transgenic mice.  RAG-1 or RAG-2 specific antibody was used, 
followed by qPCR with 250 pg DNA in duplicates.  Amount of RAG-1 or RAG-2 protein 
at different gene locations ((IP/Inputcorr) was calculated as described (Ji et al., 2010).  
Primers for amplification are indicated by the red bars in the schematic above each 
figure.  Data is from two independent experiments for each founder.  Founder set 1 is on 
top and founder set 2 is on bottom for (A).  Only data for founder set 1 was generated for 
the RAG-2 ChIP in (B).  Immunoprecipitates were analyzed in duplicates.  Error bars 








Genome-Wide DNase I Hypersensitivity Study Of The Eμ Enhancer On 















Gene regulatory sequences that exert developmental and tissue-specific control 
often undergo changes in DNase I-sensitivity that parallel transcription factor occupancy 
(Lazarovici et al., 2013).  Such regulatory genes include the mouse proto-oncogenes, c-
fos and c-myc, whose DNase I-sensitivity changes as a result of transcription induction 
(Chen et al., 1987; Chen et al., 1990).  These active regulatory sequences are associated 
with the presence of DNase I hypersensitive sites in the genome since DNA binding at 
these sites is more accessible to transcription factors and accessory proteins due to their 
nucleosome depletion (Gross and Garrard, 1988).  The location of DNase I hypersensitive 
sites (DHSs) in a genome is then critical to understanding where regions of open 
chromatin exist that regulate gene expression in a developmental and tissue-specific 
manner (Sheffield et al., 2013). 
Several DHSs have been previously identified within the immunoglobulin (IgH) 
locus of mouse chromosome 12.  At the 5’ end of the locus, a cluster of four DHS peaks 
near Zfp386, a Kruppel-like zinc finger protein, were located 30 kb upstream of the last 
5’ VH  gene (Pawlitzky et al., 2006).  Further analysis on these sites revealed no 
relationship to allelic exclusion or gene recombination (Matheson and Corcoran, 2012).  
In the 100 kb VH to DH intergenic region, which is between the 3’ most VH gene 
(V7183.1.1pg) and DFL16.1, six hypersensitive peaks were identified where three of the 
sites were shown to have an insulator sequence that contains CTCF-binding elements 
(Featherstone et al., 2010).  It was proposed that the function of these CTCF sites serve as 
a barrier element to recombination and prevent spurious germline rearrangements 
between VH, DH, and JH gene segments.  Within the DH gene segment, the intervening DH 
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genes are insensitive, while the outer 5’ DFL16.1 and 3’ DQ52 have been reported to be 
mildly sensitive and hypersensitive to DNase I, respectively (Chakraborty et al., 2009).  
Three additional DHS clusters have been identified that are important in the IgH locus.  
This includes the four sensitive JH genes that are ~1 kb 3’ of DQ52 (Maës et al., 2006), as 
well as a cluster of hypersensitive peaks in the 3’ region of the IgH locus that led to the 
identification of the 3’ regulatory region (3’RR) (Giannini et al., 1993; Michaelson et al., 
1995).  This 3’RR is critical for somatic hypermutation and class switch recombination, 
but not for V(D)J joining (Rouaud et al., 2012).   
The only DNase I hypersensitive site on the IgH locus that has been demonstrated 
to have a significant role in both epigenetic modifications and V(D)J recombination is the 
700 bp Eμ enhancer located in the intronic region between JH4 and Cμ (Chakraborty et 
al., 2009; Mills et al., 1983).  Whereas the Eµ enhancer is critical for activating IgH 
transcription and recombination, it remains unknown whether it is also involved in 
regulating genes distant from the IgH locus, as well as those located on other 
chromosomes.  Earlier studies demonstrated that DHS associated with the DQ52 
promoter was lost upon deletion of the Eµ enhancer, which has been attributed to the 
promoter becoming inactive by loss of the Eµ enhancer (Chakraborty et al., 2009).  Based 
on this observation, we reasoned that one way to search for Eµ-mediated interactions 
elsewhere in the IgH locus and on other chromosomes was to screen genome-wide for 
DHS sites that are lost upon deletion of the Eµ enhancer.  We used genome-wide DHS 
sequencing to probe the open chromatin structure at the single nucleotide level to 
determine whether the Eµ enhancer in mouse pro-B cells affects other genes on 
chromosome 12 or elsewhere in the murine genome.  Our results show unique DHS 
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peaks in some areas of the IgH locus in both the presence and absence of the Eµ 
enhancer.  In addition, our preliminary analysis did not detect the Eµ enhancer having an 
effect on other genes in other chromosomes, although this remains to be completed using 






















DNase I-seq is a global and high-resolution method that uses the nonspecific 
endonuclease DNase I to map chromatin accessibility. These accessible regions are 
designated as DNase I hypersensitive sites (DHSs) and define sequences of regulatory 
potential (e.g., promoters, enhancers, insulators, and locus control regions) in complex 
genomes.  In this study, the B6D345, Rag8-/- and Rag2-/- Eµ-/- cell lines were used to 
screen any changes in DHS peaks genome wide as a result of Eµ enhancer deletion.  Both 
Rag8-/- and Rag2-/- Eµ-/- cell lines are from the 129 mouse strain, while the B6D345 
cell line is from the C57BL/6J strain.  The B6D345 cell line was included as a wild-type 
control since it maps directly to the C57BL/6J reference strain on the UCSC mm9 
genome browser.  A complete description of these cell lines and the DHS experiment is 
given in the Materials and Methods section.   
Briefly, 1 x 107 nuclei from cell lines carrying wild-type or Eµ-deleted IgH alleles 
were digested with a range of concentrations of DNase I (Worthington-Biochem, 
catalog# DPFF), in order to separate the most accessible chromatin into short fragments.  
Typically, a range of 0 to 100 units/ml of DNase I concentrations were used per 1 x 107 
nuclei.  One critical aspect that was primary to the success of this experiment was the 
replacement of Mg+2 with Ca+2 in the digestion buffer to slow the enzymatic activity of 
DNase I prior to ultracentrifugation (Figure 18).   Real-time PCR was also used to 
determine the optimal level of DNase I enzyme to prevent over-digestion (Figure 19).  
This was reflected in several ways.  First, the real-time PCR results demonstrated little 
digestion for insensitive genes at all concentrations (NFM, Cy3, β-globin).  But, for 
hypersensitive gene regions (Eμ, β2M, DQ52), there was increasing loss of DNA with 
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increasing units of DNase I (Figure 19A,B).  When Eμ is deleted in the Rag2-/- Eµ-/- cell 
line, specific IgH hypersensitive loci are insensitive, including DQ52 and Eμ (Figure 
19C).  Second, the parent band in the gel was intact at all concentrations, with minimal 
smearing underneath at the 20 unit concentration of DNase I (Figure 18b).  This is 
important, as extensive smearing below the parental DNA band is related to overgrown 
cells, endogenous nuclease activity, or over-digested chromatin.  Overall, we found that 
the optimum amount of DNase I enzyme is at 20 units/ml for 10 million cells, as it 
produced clear and consistent sequencing tracks on the UCSC genome browser between 
samples (Figure 21). 
The short DNA fragments from the DNase I digestion were then size selected by 
ultracentrifugation over a sucrose cushion in order to enrich for 200 – 400 bp size 
fragments (Figure 20).  Fractions were then isolated in 500ul volumes and purified.  The 
size-selected DNase I hypersensitive DNA was then prepared for high-throughput 
sequencing.  DNA was ligated with adaptors and amplified to generate a DHS library for 
single-end sequencing on the Illumina Genome Analyzer (Illumina, catalog # PE-102-
1004).  We obtained 13.6 to 21.6 x 106 non-redundant sequence tags for three samples, 
repeated two times at DNase I concentrations of 10, 20, and 40 units/ml.  Data from the 
Illumina Genome Analyzer was then analyzed using manufacturer-provided software, 
uploaded to the UCSC Genome browser, and aligned to the mm9 database (NCBI Build 





Results and Discussion 
First, we found that our genome-wide DHS results were consistent between 
samples in housekeeping genes that are known to be hypersensitive outside of the IgH 
locus on mouse chromosome 12.  In figure 21, β2-microglobulin, Mb-1, and E2A are all 
used as examples to demonstrate the consistent peak and patterns that are observed 
upstream of the respective gene promoters between samples.  Also shown in the top track 
of figure 21 is an outside reference from a DHS experiment using mouse spleen B Cells 
(CD43-, CD11b-) from the Stamatoyannopoulous Laboratory at the University of 
Washington. 
Second, there was consistency in peaks between different samples across the 
entire IgH locus (chr12: 114,500,000 – 117,500,000) (Figure 22A).  There were no 
significant gaps in the sequence between samples and there was remarkable similarity 
between samples at both the 5’ and 3’ ends (Figure 22A).  Along with this, there were no 
discrepancies in mapping the 129 mouse cell line strains (Rag8-/- and Rag2-/-Eµ-/-) to the 
mm9 database that uses the C57BL/6 sequence, as there was exact alignment with the 
B6D345 cell line that is from the C57BL/6 mouse strain.  Moreover, the sequencing 
readout also clearly showed a peak corresponding to the Eµ enhancer 
(chr12:114,665,501) in both sets of cell lines that contain wild-type IgH alleles, while no 
peak was present in the same position for the cell line with Eµ - deficient alleles (Figure 
22B).  These results support the real-time PCR data (Figure 19) and previous data that 
demonstrated Eµ dependent affects with DQ52 and DFL16.1 (Chakraborty et al., 2009).  
Specifically, when the Eµ enhancer was present, both Eµ and DQ52 demonstrate strong 
hypersensitivity in the qPCR (Figure 19A, 19B) and the genome-wide DHS sequencing 
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data (Figure 22B).  When the Eµ enhancer was absent in the Rag2-/- Eµ-/- cell line, there 
was significant loss of the DQ52 (chr12: 114,668,794)  associated DHS signal (Figure 
19C) and peak (Figure 22).  Likewise, DFL16.1 (chr12: 114,720,334) was moderately 
sensitive when the Eµ enhancer was present and this peak was reduced when the 
enhancer is absent (Figures 19C, 22B). 
Such consistency in the trends from the genome-wide DHS tracks for both within 
and outside the IgH locus allowed deeper exploration of the data to explore the effects of 
the Eµ enhancer both within the IgH locus and outside of it.  Two additional tracks are 
present in Figure 22 that allows comparison to mouse pro-B cell and spleen B cell DHS 
peaks.  The mouse spleen B cell (CD43-, CD11b-) DHS is from the Stamatoyannopoulous 
Laboratory at the University of Washington (UW) and the mouse pro-B cell DHS is from 
the Busslinger laboratory at Vienna Biocenter (VB).  In particular is the identification of 
a unique DHS peak that is approximately 20 kb upstream of the Eµ enhancer at position 
114,684,105, between DQ52 (chr12: 114,668,794) and DST4 (chr12:114,686,510).  This 
peak is present in all tracks where the Eµ enhancer is present except for the spleen B cell 
DHS.  When the Eµ enhancer is absent in the Rag2-/- Eµ-/- track (Figure 22B, bottom), the 
peak at 114,684,105 is reduced to the same level as DQ52.  Therefore, this site represents 
a new area of regulation by the Eµ enhancer and may have a role in DH to JH 
recombination since it is adjacent to the outer DSP gene segment, DST4. 
In addition, we identified two other significant DHS-peaks within the IgH locus 
not dependent on the Eµ enhancer.  The first peak was between Cγ1 and Cγ2b located at 
position 114,558,806 - 114,560,261 on mouse chromosome 12 (Figure 23).  The peak 
was significantly stronger than other peaks within the 400 kb window in Figure 23, and 
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therefore represents a potentially significant cis-acting element.  It was also present in the 
VB data track and was absent in the UW data track.  It is of particular importance to note 
the consistency of the presence of the peak in all three samples (Rag8-/-, B6D345, and 
Rag2-/- Eµ-/-) (Figure 23).  One way to compare the relative strength of DHS peaks in 
terms of sensitivity is to compare them to known hypersensitive sites.  The IgH 3’RR has 
four enhancers (hs3a, hs1.2, hsb, and hs4) and four DNase I hypersensitive sites were 
identified, known as hs5-8 (Garrett et al., 2005).  These sites are located ~25 kb 
downstream of the most 3’ CH genes, Cα (Pettersson et al., 1990).  Since it is known to 
have strongly hypersensitive sites, comparison of peaks to the 3’RR is one way to assess 
the relative strength of DHS peaks.  This peak between Cγ1 and Cγ2b was present in the 
Rag8-/-, B6D345, and Rag2-/- Eµ-/- tracks and was similar to the sensitivity in the 3’RR.  
Yet, in the VB data, the 3’RR DHS peaks were significantly reduced and therefore it is 
difficult to assess the relative strength of this peak between Cγ1 and Cγ2b in this track.  
One reason for this difference between data sets is due to the methods used to prepare the 
DNase I digested DNA for sequencing.  As noted in the Materials and Methods section, 
several steps were implemented into the protocol to prevent over and under-digestion of 
samples in order to execute the purpose of identifying other potential cis-regulatory 
elements.  Our interpretation is that the VB DHS track was over-digested with DNase I 
enzyme, as noted for the 3’RR and also for DFL16.1.  When genome-wide sequencing 
DHS is performed on higher units of DNase I enzyme that reflect an overly digested 
state, which is based on additional gel smearing in the gel bands prior to 
ultracentrifugation and less than 80% of DNA remaining in the pre-sucrose sample 
measured by qPCR, the DHS peaks are reduced (data not shown). 
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The second unique peak identified was located at position 115,850,147 - 
115,850,965 on mouse chromosome 12 (Figure 24).  This is the same location of 
J558.8.98, which is a VH gene segment that is upstream of J558.6.96 (chr12:115,821,780-
115,822,073) and downstream of J558.9.99 (chr12:115,854,061-115,854,354).  This peak 
has several features that lend it to appear as a significant cis-regulatory element.  First, 
within the 400 kb window shown from the UCSC genome browser, it is the tallest peak 
in the region for the Rag8-/-, B6D345, and Rag2-/- Eµ-/- tracks.  Second, its average 
peak height between samples is 6.4, which is comparable to other enhancer regions on the 
IgH locus, including the 3’RR (7.5) and the Eµ enhancer (8.4). While this peak was 
present in both the UW and VB tracks, it is not the strongest DHS in the 400 kb window 
for these tracks (Figure 24).  This peak was not present in either a fibroblast or embryonic 
stem cell DHS from ENCODE (data not shown).  Therefore, this unique peak in the 
Rag8-/-, B6D345, and Rag2-/- Eµ-/- tracks is specific for pro-B cells and may have be 
involved in positioning the IgH locus for V(D)J rearrangement. 
Lastly, there have been previous reports of other DHS peaks on the IgH locus 
(Figure 25).  This genome-wide DHS study allowed comparison between DHS sensitivity 
peaks across the IgH locus.  A specific window of the 3’RR is given in figure 25A to 
assess the other areas of the IgH locus.  There have been six DHSs identified within the 
100 kb intergenic VH – DH region (Featherstone et al., 2010), and four DHS peaks 30 kb 
upstream of the last VH gene, J558.89pg.195 (chr12: 117,263,407) (Pawlitzky et al., 
2006) (Figure 25).   In the present genome-wide DHS-seq analysis, only HS4 was 
identified within a 10 kb region upstream of DFL16.1 that is within the 100 kb intergenic 
VH – DH region (Figure 25).  Every other peak within the region was of only weak to 
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moderate sensitivity.  One significant peak was detected 30 kb upstream of the last VH 
gene near Zfp286, which is referred to as Hs3b in the Pawlitzky study, but all other peaks 
in this region were also only moderate to weak in DNase I sensitivity (Figure 25).  
Therefore, one distinct advantage of this genome-wide DHS study in pro-B cells is the 
global view afforded to the IgH locus to interrogate all significant DHS peaks.  Not all 
reported peaks are strong hypersensitive sites, and only a limited number of peaks appear 
significant on the IgH locus.  The exact significance of weak and moderate hypersensitive 
sites needs further exploration.  
Furthermore, more in-depth bioinformatic analysis on these sequencing results 
will take place to identify other potential regulatory elements.  Using excel-based 
algorithms, there were no detectable regions in the genome that appeared to be affected 
by the loss of the Eµ enhancer in the Rag2-/- Eµ-/-.  This does not exclude the possibility 
of a trans regulatory activity for the Eµ enhancer, but finer techniques to identify DHS 
hotspots as a result of Eµ loss will need to be applied to determine the extent of the Eµ to 
other regions of the genome. 
We reached several significant conclusions based on this this finely tuned DHS 
experiment and results.  First, the genome-wide mapping of DNase I hypersensitive 
(DHS) sites in mouse pro-B cells has revealed novel hypersensitive sites within the IgH 
locus.  One significant peak was identified in this study that appears to be regulated by 
the Eµ enhancer.  Due to the peak’s position near DST4, this intergenic region likely has 
a role in DH to JH gene rearrangement.  Two other significant peaks were identified in this 
study, but they were present even in the absence of the Eµ enhancer.  Therefore, while 
the Eµ enhancer directly affects some regions of the IgH locus, such as DQ52, it does not 
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affect other regions that appear to be significant.  The function of these novel peaks needs 
to be further explored, as they may have a role in pro-B cell development.  This includes 
positioning the locus for V(D)J rearrangement and even other mechanisms, such as allelic 
exclusion and class-switch recombination.  Second, there are different levels of DHS 
sites, from strongly hypersensitive to weakly hypersensitive that can only be viewed 
across the genome in a DHS-seq analysis.  While several labs have reported DHS sites in 
general terms for the IgH locus, the exact strength of each DHS site can only be viewed 
when the whole locus is sequenced.  Different laboratories have reported many DHS sites 
along the IgH locus (Figure 5), but only when these sites are viewed as a whole can the 
strength of each individual peak be ascertained.  Many of the DHS sites reported on the 
IgH locus, especially in the intergenic VH - DH region, are weak sites that likely serve no 
regulatory function.  On the other hand, several sites, including those identified in this 
study, have a strong DHS signal, and likely serve a gene regulatory purpose for the IgH 
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Figure 18.  Pre-sucrose DHS gel to Validate DNase I Digestion.  Nuclei from 
DNase I-digested samples were warmed to 550C and 3 ul from each of the 
digested samples were loaded onto a 1% agarose gel and set to run for 45 
minutes at 120V.  Comparison between over-digested DNA (A) and 
properly digested DNA (B).  The difference between the experiments is the 
replacement of Mg+2 with Ca+2 in the digestion buffer to slow down the activity 
of the DNase I enzyme.  When Ca+2 is used during the digestion step, a strong 
and distinct parent band is observed across each digested sample, whereas large 
smearing and loss of the parent band indicates a poor sample (A).  Smearing may 

























































Figure 19.  qPCR Validation of DNase I sensitivity.  Nuclei from each cell line (A) 
Rag8-/-, (B) B6D345, and (C) Rag2-/-Eμ-/- was digested with different concentrations of 
DNase I (X-axis), and the DNA was then purified from 5 x 105 nuclei and a total of 2 ng 
used for qPCR.  Primers were used for both inside the IgH locus (top graph) and outside 
(bottom graph).  Primer locations for inside the IgH locus are indicated by the black bars 
underneath each schematic.  Primers for outside the IgH locus include the following: 
NFM (chr14:68,741,992), β-globin (chr7:111,010,093) and β2M (ch2:121,973,178).  The 
proportion of DNA remaining (Y-axis) was normalized to NFM (top graph) or Cγ3 
(bottom graph), as described in the Materials and Methods section.  Increased DNase I 
sensitivity is demonstrated with increasing loss of signal as the concentration of DNase I 
increases.  Results are shown for two independent DNase I digestion experiments and 




Figure 20.  Size Fractionation of DNase I Released Fragments.  Nuclei from each cell 
line was isolated and subsequently subjected to limited DNase I digestion.  Small DNA 
fragments containing DNase Hypersensitive Sites were purified by size selection over a 
sucrose gradient and 500 ul fractions were collected.  The top of the gradient contains the 
small fragments (<600 bp) (lower left side of gel), while the bottom of the gradient 
contains the high molecular weight fractions (upper right side of gel).  Only those 












Figure 21.  Consistent DHS Peaks In The Genome Outside of the IgH locus.   
High-throughput sequencing was carried out to obtain 40-nucleotide sequence tags, 
which were mapped back to the genome and uploaded to the UCSC genome browser to 
visualize clusters of sequence tags that indicate a DHS site. Four tracks are shown in the 
UCSC Genome Browser in each figure above for DHS sites that correspond to (A) β2M 
(ch2:121,973,178), (B) Mb-1 (chr7:25,682,532), and (C) E2A (chr10:79,896,898).  In 
each figure, the top track is Mouse Spleen B Cells (CD43-, CD11b-) from the 
Stamatoyannopoulous Laboratory at the University of Washington (GEO dataset: 
GSM1003813); the next track is Rag8-/-, followed by the B6D345 control in the 
subsequent track, and Rag2-/-Eμ-/- in the bottom track.  Results are representative from 
two independent DNase I digestion experiments for 20 units of DNase I digestion.  
Enrichment on the Y-axis is measured by the number of sequence tags per million, except 








Figure 22.  DHS Tracks Demonstrate Eµ Sensitivity for Correct Genotypes.  Five 
tracks of DHS sites that cover the IgH locus are displayed in the UCSC Genome Browser 
in each figure above.  In figure A the browser image is the complete IgH locus on 
chromosome 12: 114,500,000 – 117,500,000.  A zoomed in 100 kb view that displays the 
area between the Eμ enhancer and the first VH gene, VH7183.3, is in figure B. In both 
figures, the first track is mouse spleen B Cells (CD43-, CD11b-) from the 
Stamatoyannopoulous Laboratory at the University of Washington (UW) (GEO dataset: 
GSM1003813).  The next track is mouse Pro-B cells from the laboratory of Meinrad 
Busslinger at Vienna Biocenter (VB) (GEO dataset: GSM932968).  The next three tracks 
are Rag8-/-, followed by B6D345 and Rag2-/- Eμ-/- in the bottom track.    Results are 
representative from two independent DNase I digestion experiments for 20 units of 
DNase I digestion.  The location of the Eμ deletion at position 114,665,501 is shown by 
the red arrow in figure B.  Also shown in figure B are DQ52 (chr12:114,668,722) and 
DFL16.1 (chr12:114,720,385).  A unique peak was identified at position 114,686,105, 





Figure 23.  Unique DHS peak identified between C-γ1 and C- γ2b.  DHS peak 
location is between 114,558,806 - 114,560,261, as indicated by the red bar, on mouse 
chromosome 12 and is the largest peak within a 200 kb window in each of the three 
tracks at the bottom of the UCSC Genome Browser above. The first track is mouse spleen 
B Cells (CD43-, CD11b-) from the Stamatoyannopoulous Laboratory at the University of 
Washington (UW) (GEO dataset: GSM1003813).  The next track is mouse Pro-B cells 
from the laboratory of Meinrad Busslinger at Vienna Biocenter (VB) (GEO dataset: 
GSM932968).  The next three tracks are Rag8-/-, followed by B6D345, and Rag2-/- Eμ-/- in 
the bottom track.    Results are representative from two independent DNase I digestion 




Figure 24.  Unique DHS peak at J558.8.98.  (A) Peak location is between 115,850,147 
- 115,850,965 on mouse chromosome 12, as indicated by the red arrow.  The first track is 
mouse spleen B Cells (CD43-, CD11b-) from the Stamatoyannopoulous Laboratory at the 
University of Washington (UW) (GEO dataset: GSM1003813).  The next track is mouse 
Pro-B cells from the laboratory of Meinrad Busslinger at Vienna Biocenter (VB) (GEO 
dataset: GSM932968).  The next three tracks are Rag8-/-, followed by B6D345, and Rag2-
/- Eμ-/- in the bottom track.  This is a significant peak that appears as the tallest in only the 
three tracks displayed below the UW and VB tracks in the UCSC Genome Browser 
above.  Within the 100 kb window above, this peak is surrounded by a cluster of smaller 
peaks for the three bottom tracks.  Results are representative from two independent 











Figure 25.  DHS Peaks within the intergenic DH to VH region upstream of the last 5’ 
VH gene. UCSC genome browser display of DHS sites within and near the IgH locus.  
Above each figure is a schematic that shows the broad region of view within the IgH 
locus.  Beneath each figure is a gene schematic of the specific region.  (A)  100 kb view 
of the 3’RR to Eµ region of the IgH locus.  (B) 100 kb view of the intergenic region 
between DFL16.1 and VH 7183.2.3.  The red arrow indicates the location of HS4as 
identified by Featherstone et al., 2010. (B) 30 kb region upstream of the last VH gene, 
J558.89pg.195, near Zfp386.  The red arrow is the location of Hs3b as identified by 
Pawlitzky et al., 2006. 
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Materials and Methods 
 The following methods and materials describe the protocols used to execute the 
experiments.  Most experiments, including PCR, were carried out under sterile conditions 
in a tissue culture hood, and then transferred to a laboratory bench when appropriate.  
The exception is the Southern Blot procedure.  Autoclaved tips were always used, 
including cut-tips to handle nuclei and other fragile samples. 
 
 
Cell Culture Media 
RPMI-RAG Media: 
Bone marrow derived pro-B+ cell lines were maintained in sterile tissue culture 
conditions.  Media composition was as follows:  RPMI-1640 medium (Invitrogen, 
catalog #11875-093) supplemented to contain 10% Fetal Bovine Serum, 1% Penicillin-
Streptomycin-Neomycin (PSN) Antibiotic Mixture (Invitrogen, catalog # 15640-055), 
and 50 µM 2-mercaptoethanol.  Media was filtered into a sterilized autoclaved bottle.  
Cell lines were maintained consistently at a density 0.5 x 105 – 1.5 x 106 cells/ml.  Prior 
to experiments, cells were >98% viable upon trypan blue stain.  This media was 
designated “RPMI-RAG” media because of its components and use with cell lines 
associated with RAG deficiency.  
 
OP-9 Media: 
OP-9 media consisted of the following components: Minimum Essential Medium Alpha 
(Invitrogen, catalog number 11095-072), supplemented with 20% fetal bovine serum 
(Hyclone), 100 U/mL penicillin, 100 μg/mL streptomycin, and 1× L-glutamine 
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(Invitrogen); media was filtered into a sterilized autoclaved bottle and plated 1 or 2 days 
before use in 24-well plates (Corning) to achieve a final concentration of 2 x 105 cells/ml 
prior to transfer into a T-25 flasks.  One day prior to primary pro-B cell plating, cells 
were plated in a T-25 flask at 3 x 105 cells/ml. 
 
Primary Pro-B Cell Media: 
Freshly isolated CD19+ pro-B cells from mouse bone marrow tissue were plated on OP-9 
cells, supplemented with 1ug IL-7, in media that contained the following: 500 ml OPTI-
MEM  (Invitrogen, catalog #11058-021), 4% Fetal Bovine Serum, and 1% Pen-Strep 
(Invitrogen).  Media was filtered into an autoclaved bottle prior to use. 
 
Cell Culture: Cell Lines, OP-9 and Primary Cells 
Three mammalian bone marrow pro-B+ derived cell lines were used in projects 1 and 2 of 
this thesis:  B6D345, RAG2 deficient (RAG8-/-), and RAG2-/- Eμ-/-.  Each of these cell 
lines were grown in the described “RPMI-RAG Media.”  The B6D345 pro-B cell line is 
from a C57BL6 mouse and has an inactive RAG1 allele (Ji et al., 2010), and was kindly 
provided by Dr. David Schatz (Yale University).  Abelson transformed RAG2-/-, referred 
to as RAG8-/- in this thesis, and RAG2-/- Eμ-/- were cultured in sterile tissue culture 
conditions and were maintained consistently at a density 0.5 x 105 – 1.5 x 106 cells/ml.  
Prior to experiments, cells were >98% viable upon trypan blue stain.  OP-9 stromal cells, 
which are derived from bone marrow of the op/op mouse, support primary pro-B+ cell 
growth in culture (Vieira and Cumano, 2004), and were a kind gift from Dr. Jagan 
Pongubala and were maintained in the described “OP-9 Media.”  These cells were not 
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grown longer than 10 days, unless used for primary-B cell experiments. Primary bone 
marrow derived CD19+ pro-B cells were plated using a total of 3 x 106 cells on an OP-9 
stromal layer plated 1 day prior at 3.0 x 105 cells/ml.  Primary pro-B cell concentration 
during growth and expansion phase ranged from 1.5 x 106 to 2.0 x 106 cells/ml.  Total 
number of primary pro-B cells never exceeded 40 million cells per T-75 Tissue Culture 
Flask (Corning, catalog # 430641).   Media used for primary pro-B cell growth was the 
described “Primary Pro-B Cell Media.”  All cells were cultured in sterile tissue culture 
conditions, maintained in 37 0C incubators, and counted using a Hemocytometer. 
 
Generation of Transgenic Mice 
The BAC used to generate each transgenic mouse was derived from BAC RP23-458I14 
(Invitrogen).  The vector sequence is from the pBACe3.6, which is an 11 kb backbone 
that contains both a Sacb gene and PI-SceI linearization enzyme.  The RP23-458I14 
insert was estimated to be 181 kb based off PCR.  BAC vectors were injected into 
C57BL\6 mice by pronuclear injection. 
 
Mouse and Cell Line Genotyping 
All the pro-B+ cell lines and mouse colonies, including the transgenic mice, C57BL\6, 
JHT, hs5,7-deficient, and Pax5+/- x Rag2-/-.  For the pro-B+ cell lines, which includes 
B6D345, Rag8-/-, and Rag2-/-Eμ-/-, the following primer sets were used: Eμ-5’(Up) , Eμ-3’ 
(Down), Emu5F, and Emu2R .  A full outline of primers is given in the Figure 7 legend.  
Figure 7A below depicts primer locations in red bars, and key restriction sites with 
upside-down purple arrows.  To genotype pro-B+ cell lines, the following combinations 
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of primers were used: (a) Eμ-5’ and Eμ-3’(b) Emu5F and Emu2R.  Primer set (a) is 
outside of the XbaI-EcoR1 Eμ location and yields a PCR fragment size of 1,120 bp for 
Eμ+/+ pro-B cells (B6D345 and Rag8-/-), while this same primer set has a size of 900 bp in 
the Eμ deficient pro-B cell line, Rag2-/-Eμ-/- (Figure 7B).  The Eμ deletion is between the 
two Hinf1 enzyme sites in the Rag2-/-Eμ-/- pro-B cell line.  Using both primer sets allows 
detection and prevention of heterozygosity, mixed samples, or contamination.   
 For the transgenic mice, several different primer sets were used to test for the 
transgene in the JHT background mice (Figure 7).  These sets included the above listed 
primer sets, Eμ-5’, Eμ-3’, Emu5F, and Emu2R, and in addition, relocated primer sets, 
along with a specific primer that anneals to the Bac backbone (Sacb).  Figures 7B-E are 
examples of genotyping the different transgenic mice with the different primer sets. 
 All PCR reactions for genotyping used the following reagents from Qiagen’s 
HotStarTaq DNA Polymerase (Catalog # 203205) kit that is listed below.  A PCR 
mastermix was set up using the following conditions: 
10xPCR 5ul 
MgCl2 2ul 





All PCR Reactions, except JHT, were executed under the following PCR cycling 
conditions: 
Step Temperature Length 
1 95 deg 15 min 
2 94 deg 45 sec 
3 58 deg 45 sec 
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4 72 deg 1:20 min 
5 72 deg 10 min 
6 4 deg Forever 
Steps #2-#5 were repeated 30 times. 
JHT PCR cycling conditions are as follows: 
Step Temperature Length 
1 94 deg 2 min 
2 94 deg 30 sec 
3 56 deg 1 min 
4 72 deg 1:30 min 
5 72 deg 10 min 
6 4 deg Forever 
Steps #2-#5 were repeated 30 times. 
PCR conditions to test DH to JH rearrangements are as follows: 
Step Temperature Length 
1 95 deg 15 min 
2 94 deg 45 sec 
3 62 deg 45 sec 
4 72 deg 1:20 min 
5 72 deg 10 min 
6 4 deg Forever 
Steps #2-#5 were repeated 33 times. 
  
 Purification of CD19+ pro-B cells 
 Bone marrows of transgenic mouse strains were flushed using 19 G x 1in. (BD, 
catalog #305186) or 26 G x ½” needles (BD, catalog # 305111).  ACK (Ammonium-
Chloride-Potassium) Lysing Buffer was used for the lysis of red blood cells (Gibco, 
catalog # A10492-01).  CD19+ B cells were isolated by positive selection with anti- 
CD19 microbeads (Miltenyi Biotec).  All selections were performed on a Miltenyi 
automacs separator according to the manufacturer’s instructions.  The purity of selected 
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populations was assessed by flow cytometry by staining in FACS buffer (PBS, 0.5% 
BSA, 0.01%NaN3, pH 7.2-7.4) containing the appropriate, pre-titered antibodies: CD19 
PE-Cy7  (BD Biosciences, catalog # 561739), B220 FITC (BD Biosciences, catalog # 
553087), A4.1 APC (Thy1.2) (Affymetrix, catalog # 17-0902-81), IgM-APC 
(Affymetrix, catalog # 17-5790-82), CD43 PE (BD Biosciences, catalog # 553271), 
CD19 FITC (BD Biosciences, catalog # 553785). 
 
Real Time, Reverse Transcriptase PCR 
 Real-time PCR was performed on all DNase, ChIP, and transcription experiments 
using SYBR Green Universal Mix and the ABI Prism 7000 (Applied Biosystems).  For 
ChIP, input DNA from purified chromatin before immunoprecipitation, along with 
immunoprecipitated (IP) DNA was first quantified using picogreen fluorescence kit 
(Molecular Probes, Eugene, OR).  
 All real-time PCR conditions were executed using the referenced amount of DNA 
at 50 0C for 2 minutes, 95 0C for 10 minutes, and then 40 cycles of 95 0C for 15 seconds 
and 60 0C for 1 minute.  Data was collected at 60 0C.  The endpoint used in real-time 
quantification is the PCR cycle number that crosses an arbitrarily placed signal threshold, 
and this threshold is a function of the amount of target DNA present in the starting 
material.  For ChIP experiments, the threshold was set at a point at which the real-time 
PCR amplification was linear.  The fold difference for any target sequence was calculated 
to measure the fold enrichment of the target sequence in the immunoprecipitate compared 
to the total sample (input) (Litt et al., 2001): 2-ΔCt(ΔCt = Ct[IP] – Ct[Input].  For 
transcription analysis, one microgram of total RNA was reverse transcribed using 
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Superscript III (Invitrogen) and random hexamers.  Real-time PCR was performed using 
0.5 ul of cDNA for both +RT and –RT samples. 
 
Southern Blot 
Mouse DNA was isolated from tissues as outlined previously (Strauss, 2001).  Ten 
micrograms of genomic DNA was completely digested overnight at 37 °C with different 
restriction enzymes (5 units) in a total volume of 500ul.  Samples were then precipitated 
the next day by ethanol precipitation and resuspended in 15 µl 10mM Tris pH 7.5.  
Subsequently, samples underwent electrophoresis in 1x TBE at 35V for 16 hours.  The 
gel was then treated with 0.25 M HCl to fragment the high molecular weight DNA into 
small pieces.  After this, the DNA was denatured and transferred overnight onto a 
GeneScreen Plus (PerkinElmer) membrane using alkaline transfer buffer (0.4 M NaOH, 1 
mM EDTA).  To probe for the DNA on the blot, genomic DNA was amplified using 
primers for the area of interest, and the DNA was radiolabeled with [32P]–α-deoxy-CTP 
using the NEblot kit (New England Biolabs).  Blots were hybridized overnight at 62°C, 
washed the next, and the band patterns were detected using phosphorimaging screens and 
a Storm 860 phosphorimager (GE Healthcare Life Sciences). 
 
Chromatin Immunoprecipitation 
ChIP experiments on modified histones and RAG-1/-2 were performed using methods 
similar to those described previously (Ji et al., 2010; Chakraborty et al., 2009; 
Chowdhury and Sen, 2001; Lu et al., 2004).  Approximately 10 million CD19+ pro-B 
bone marrow cells, maintained prior at a cell concentration of 1 x 106 cells/ml, were 
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cross-linked for 5 minutes using 1% formaldehyde and quenched with 0.125 M glycine 
on a steady rocker.  The cells were then lysed with SDS buffer (1% SDS, 50 mM Tris-
HCl pH 8, 10 mM EDTA) and sonicated twice on ice/water using a Bioruptor to reduce 
the DNA length to approximately 500 – 1000bp.  The debris was removed by 
centrifugation and the sonicated chromatin was then placed in ChIP dilution buffer (167 
mM NaCl, 1.2 mM EDTA, 1.1% TX-100).  Sonicates were pre-cleared with 5ug of 
nonspecific IgG, an input sample was saved, and immunoprecipitated with the following 
antibodies: anti-H3K9ac (Millipore, 06-942), anti-H3K9me2 (Millipore 07-441) anti-
H3K4me3 (Active Motif, 39159) and rabbit immunoglobulin G (IgG; Santa Cruz, sc-
2027).  Immune complexes were then collected with protein A, washed, and eluted with 
sodium bicarbonate-SDS (1% SDS containing 0.1 M NaHCO3), and the cross-links were 
reversed by heating at 65 °C for 6 hours, followed by proteinase K treatment, two phenol 
extractions, and ethanol precipitation.  Chromatin, including the input and 
immunoprecipitated DNA samples, was quantified using fluorometrically using 
PicoGreen (Molecular Probes-Invitrogen, P7589).  Real-time PCR was used to determine 
the abundance of target sequences in the immunoprecipitated relative to the input 
according to manufacturer’s instructions on an ABI 7500 apparatus (Applied Biosytems). 
Each real-time PCR used 200 pg DNA, performed in duplicates, and each ChIP was done 
in duplicates or triplicates.  The oligonucleotide sequences are presented in the Materials 
and Methods section under Primers and Probes.  The abundance of RAG-1 or RAG-2 at 




Genome-wide DNase I Hypersensitivity 
 DNase Hypersensitivity was performed using methods adapted from those 
described previously (John et al., 2013).  Modifications to the conditions of previously 
described methods were made specifically for primary B-cells, B-cell lines, and 
consistent results.  Buffers were always prepared prior to experiment.  Concentration of 
cells in culture for experiment was always between 1.0 – 1.5 x 106 cells/ml.  The source 
of the DNase I enzyme was Worthington-Biochem (#DPFF), and powder was dissolved 
in sterile nuclease-free water to a concentration of 1 unit/ul, aliquoted in 20ul volume and 
placed in -800C.   Experiments were always performed using a limiting range of DNase I 
concentrations to liberate the most accessible regions in chromatin, always including 
undigested “0 units” and over-digested >40 units.  A total of 10 million cells were used 
for one DNase I digestion and titration, and the enzyme was diluted and titrated prior to 
application to cells.  Experiment efficiency was greatest when the maximum number of 
cells used for one experiment did not exceed 50 million. 
 Briefly, cells were pelleted and washed twice with cold dulbecco's phosphate-
buffered saline that contained EDTA-free protease inhibitor (Roche 11873580001).  Cells 
were then suspended in cold 1x DHS-B buffer (100mM Tris-HCl (pH 7.4), 100mM 
NaCl, 30mM CaCl2, 0.5 mM spermidine, protease inhibitor) in a total of 2ml and stored 
on ice.  Nuclei was then purified and released by hypotonic lysis in the presence of 0.5% 
NP-40.  After this point, only sterile, cut tips were used to handle the nuclei.  The nuclei 
was then washed once with 1x DHS-B buffer.  During this wash, titration of DNase I 
enzyme took place.  It was essential to minimize the time of thawing the DNase I enzyme 
and applying to the reaction tubes.  Nuclei were then diluted and digested with different 
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amounts of DNase 1 (Worthington) for 3 min at 37 °C in a total volume of 250ul of 1x 
DHS-B buffer.  Reaction was terminated with an equal volume of stop buffer (0.5M 
EDTA, (pH 8.0 (10mM final)), 1x DHS-B buffer, 20% SDS (2% Final), Proteinase K (25 
μg/ml final concentration)), and incubated at 55 °C for a minimum of 2 hours.  Next, 
RNase A (Invitrogen 20 mg/ml RNase A) was added and sample was incubated at 37 °C.  
After DNase I treatments, the samples are subjected to careful phenol-chloroform 
extractions using 1.5 ml phase lock gel heavy tubes (5 Prime # 2302810) and stored at +4 
°C.  At this point, a small aliquot of DNA was recovered and ethanol precipitations were 
performed for gel electrophoresis and quantitative PCR (qPCR).  A good DNase I 
experiment was justified by both a gel that showed a parent band with minimal, yet 
increasing digestion in most samples, and a qPCR that demonstrated the shift in CT 
values described below. Control (untreated) have no digestion characteristics as observed 
in both gel electrophoresis and qPCR.  Significant smearing below the parent DNA band 
demonstrates over digested chromatin, endogenous nuclease activity, and/or sick cells.  
Lack of a parent band is indicative of either poor buffer prep or inaccurate processing of 
samples during the digestion stage.  Control samples were processed as outlined above 
but without any DNase I treatment.   
 DNase I accessibility was determined by qPCR of the DNA samples (McArthur et 
al., 2001), with several modifications.  DNase-treated DNA was quantified 
fluorometrically using PicoGreen (Molecular Probes-Invitrogen, P7589) and then diluted.  
Next, 200 pg was subjected, in duplicates, to real-time PCR using primers of similar 
amplicons size that cover either a hypersensitive or insensitive gene regions.  PCRs were 
performed using SYBR Green PCR Master Mix (Applied Biosystems #4368702) 
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according to manufacturer’s instructions on an ABI 7500 apparatus (Applied 
Biosystems).  DNase I sensitivity was measured by the percent DNA remaining 
compared to the untreated sample.  DNA content was normalized to a known DNase I-
resistant locus (Nfm).  As the number of DNase I units increases, the DNase I 
hypsensitive peaks are enriched compared to the closed, intergenic region.  The goal for 
sequencing is to select an optimal DNase I concentration for the treated sample where 1% 
of the genome has been cut and the hypersensitive sample shows selective degradation 
and the CT value increases, but there is little or no change in the CT value for the primer 
that flanks the insensitive region. Experiments were duplicated to confirm quality of 
DNase I enzyme and reproducibility.   
 Once the optimum concentration of DNase I is determined, the treated fragments 
are purified by size selection over a sucrose gradient to prepare the correct size fragments 
for sequencing.  To accomplish this, the DNase I treated nuclei are separated from the 
bulk of genomic DNA by a 24 hour x 25,000 rpm sucrose gradient ultracentrifugation 
(9% Sucrose, 5M NaCl, 1M Tris-HCl (pH 8.0), 10ml 0.5M EDTA), as previously 
described (John et al., 2013).  Samples are then carefully collected in 500ul aliquots and 
the DNA isolated by ethanol precipitation.  The size of these fragments is then completed 
by gel electrophoresis, and those fractions that are less than 500 bp are pooled together to 
construct the sequencing libraries for the Illumina Genome Analyzer.  The DNA is 
ligated with adaptors and amplified to generate a library of fragments for high-throughput 
sequencing.  A size selection step is included to limit the sequencing to fragments of 200-
400 bp, which improves the signal to noise on the sample to be sequenced.  Once the 
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DHS libraries have been sequenced and processed, they can be visualized using the 
UCSC Genome Browser (University of California Santa Cruz). 
 
Probes and Primers 
Genotyping 
 Eμ trio 3' in ctcagcctggactttcggtt 
Eμ trio 3' out accaccaaccagcatgttca 




Eμ FP ggaatgggagtgaggctctctc 
Eμ RP ctgcaggtgttctggttctgatcgg 
Eμ-3’ (Down) gtgaagccgttttgaccaga 
Eμ-5’(Up) ttcaggaccacctctgtgac 
  Southern Blot 
















  DNase Hypersensitivity 
 B2M1F  ggccaggggtttaacttctc 
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B2M1R  cttggggtttctgcttatcg 
B2M2F  ccaaaacccatggacagaac 
B2M2R  ccttgcttctagcaggtttctc 
B2M3F  tgctcttaattgtcctggcttt 
B2M3R  ggaccgccttcatttattca 
B2M4F  tgggaaagtccctttgtaacc 
B2M4R gcgcgcgctcttatatagtt 
B2M5F  tggtgcttgtctcactgacc 
B2M5R  cgggaaggagaactaaggaga 
B2M6F  tgaggctacagggtggatg 
B2M6R  ttttgcgctcagggagtcta  
B2M7F  ctctgcgatgtttccaaagc 
B2M7R  ctacctctgcctcccaagtg 
B-globin HS1_FOR agattatattgccatggtacacttgaa 
B-globin HS1_REV actggaccaattttctccctcc 
B-globin HS2_FOR agtgtcagcatattaccgatgttcc 
B-globin HS2_REV cacacagcaaggcagggtc 
B-globin HS3_FOR tgtaagtgtaaattttggagcacagg 
B-globin HS3_REV ctgaaagactaaagttcccggc 
B-globin HS4_FOR tgtttgtggtttttctgttgtatgttt 
B-globin HS4_REV  aagagcagaaaggaattaaatacacaca 
B-globin HS6_FOR cagagcattgttgaaagatgagga 









  ChIP / Transcription 







DFL16.1 (+3)_FP agcctaaaagccactcacga 
















dsp 2.11-1.5 rp tctgcctttcagcccctcttct 
DSP2.2 FP ccaggcaatgttcctgcagaatctc 


















DSP2.9 FP ccaccagaccatgttcctgcat 




DSP2s FP tgttaccttacttggcagggattt 
DSP2s RP tgggtttttgttgctggatatatc 
Emu+1_FP aagggcttctaagccagtcc 
Emu+1_RP gcagaagccacaaccataca 
Emu1F  ggctgagagaagttgggaaa 
Emu1R  caaatgagcctccaaagtcc 
Emu2F  atccgatgcatagggacaaa 
Emu2R tttgctcagcctggactttc 
Emu2R  ttgagaccgaggctagatgc 
Emu3F  cctgcaaaagtccagctttc 
Emu3R  cttgaaaaccctctcacatttt 
Emu4F  tgtccaaaattcttgtcaatcag 
Emu4R  ttgttaaaagtcagttctgaataggtt 
Emu5F  ggtcatgtggcaaggctatt 
Emu5F  atccgatgcatagggacaaa 
Emu5R tttgctcagcctggactttc 
Emu6F  acaccacctgggtaatttgc 
Emu6R  tggggaaactagaactactcaagc 
Emu7F  ggttatgtaagaaattgaaggacttt 
Emu7R  aatgcttcgggtattggaaa 
Emu8F  cagttgaacatgctggttgg 
Emu8R  tggcccattcaacaataagc 
Eusense2 gagtgaggctctctcataac 
Eμ FP ggaatgggagtgaggctctctc 
Eμ RP ctgcaggtgttctggttctgatcgg 
Eμ trio 3' in ctcagcctggactttcggtt 
Eμ trio 3' out accaccaaccagcatgttca 
Eμ trio 5' out aggaatgggagtgaggctct 
























Jh4 FP_C caccaggaattggcataa 
Jh4 RP_C cctgaggagacggtgact 
JH4FP caccaggaattggcataa 
JH4RP cctgaggagacggtgact 
Jht_seq_for cctgataggcacccaagtac  
Jht_seq_rev ttagaaattaaagacactaaagtc 
Jht_seq_rev_wt atccacccttctgatgcttg  
Nfm1F  gactggcaagcctagaatgc 




Nfm3R  ggagcaatcacgaagaggag 
Nfm451_For gctgggtgatgcttacgacc 
Nfm451_Rev  gcggcatttgaaccactctt 
Nfm4F  cttgagccttctcgtggttc 
Nfm4R  gaagcagagatccaggcact 
Nfm5F  gacgaggactggctgaagtc 




SacB anti atgttcattaagaagcttggcgc 







VDUPgS2 tcccaatacctcttataacc  
y-actin FP_C gacacccaaccccgtgacg 
y-actin RP_C gcggccatcacatcccag 
β-globin FP gccttgcctgttcctgctc 
β-globin RP attgagccctttactctctctgttc 
γ-actin FP gacacccaaccccgtgacg 
γ-actin RP gcggccatcacatcccag 
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